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CHAPTER 1 
Literature Review 
Introduction 
Diabetes is a major public health problem in the United States, with 25.6 million people 
with the disease(1).  Strategies to reduce adverse outcomes among those with diabetes 
and delay mortality are important to provide to patients and structure for healthcare 
providers. Physical activity has long been a neglected aspect of the type 2 diabetes 
treatment regimen.  Increasing physical activity is simple and relatively free for patients, 
and may provide significant benefits to insulin sensitivity, glycemic control, and overall 
health(2).  However, most studies that have researched the association between 
physical activity, sedentary behaviors, and cardiovascular disease in those with 
diabetes have been among primarily white or male populations (3-16).  This leaves the 
literature with little to no information about this association in other racial groups, like 
blacks, and women – both populations disproportionately affected by diabetes.   
Descriptive Epidemiology of Diabetes and Associated Racial Disparities 
Type 2 diabetes mellitus, often referred to as adult-onset or non-insulin-dependent 
diabetes, is a chronic disease that results from a progressive insulin secretory defect on 
the background of insulin resistance(17).  Insulin resistance is a condition in which the 
body is unable to properly use the insulin it produces.  In this stage, the pancreatic β-
cells try to compensate by increasing the levels of insulin in the blood leading to 
hyperinsulinemia.  The patient may be asymptomatic during this stage but mild 
hyperglycemia is still present.  When β-cell function decreases, the production of insulin 
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also decreases while blood glucose levels and insulin resistance increase(18) (Figure 
1).    
 
Figure 1. The natural history of insulin resistance.  (Figure from Ramlo-Halsted & 
Edelman, 2000)(18) 
Figure 2 below shows the increase in the prevalence of diagnosed diabetes across the 
United States from 2004-2009(19).  In five years, the age-adjusted prevalence of 
diagnosed diabetes rose from 5.2% to 6.3% nationwide.  The National Diabetes Fact 
Sheet from 2011 reported that in 2010, an estimated 13.0 million men and 12.6 million 
women aged 20 years or older had been diagnosed with diabetes(20).   
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Figure 2. Age-adjusted estimates of the prevalence of diagnosed diabetes among U.S. 
adults aged 20 years and older(21), 2004 and 2009.   
Blacks are disproportionately affected by diabetes, with a consistently observed higher 
prevalence of diabetes compared to whites (12.6% vs. 7.1% for 2007-2009)(20).  
Echoing the prevalence rates, blacks are at increased risk of developing incident 
diabetes when compared to whites (13.0 vs. 7.7 per 1,000 persons diagnosed in 
2010)(19).  Blacks are also younger, on average, than whites when diagnosed with 
diabetes (51.4 vs. 53.2 years old)(19).  In the Southern Community Cohort Study 
(SCCS), a large prospective epidemiologic cohort study examining racial differences in 
cancer and other chronic diseases in the southeastern United States (described in detail 
in the Methods section), which will serve as the parent cohort for the research, no 
significant difference was observed in the prevalence of diagnosed diabetes among 
blacks when compared to whites of similar (predominantly low) socioeconomic status 
and after adjustment for pertinent confounding factors(22, 23).  The Atherosclerosis 
Risk in Communities (ARIC) Project reported similar results among over 15,000 black 
and white men and women(24), suggesting that socioeconomic and other lifestyle or 
social environment factors may play a contributory role in racial disparities in diabetes 
occurrence.   
2004 2009 
3 
 
   
Summary of Epidemiologic Risk Factors Associated with Diabetes 
Health disparities in diabetes risk are hypothesized to be attributable to differences in 
risk factors such as diet, physical activity, obesity, and socioeconomic status between 
blacks and whites(25, 26).  In particular, with low socioeconomic status and obesity both 
disproportionately affecting blacks and both being positively associated with diabetes, 
much of the reported higher risk of diabetes among blacks can likely be accounted for 
by to these two confounding factors.  Other research has suggested a role for genetic 
predispositions to diabetes and diabetes-related risk factors, as discussed later(27).  
Several identified genetic variants only explain a small proportion of excess risk of 
diabetes in certain subpopulations (blacks, for instance)(28, 29).   
Many risk factors for diabetes have been identified, including poor diet, obesity and 
sedentary lifestyle, smoking, and socioeconomic status.  Obesity, particularly central or 
abdominal obesity, and weight gain are positively associated with the risk of diabetes 
(30-32).  A cross-sectional study conducted in the SCCS population reported a strong 
positive association between adult weight gain and diabetes that persisted across 
genders and racial groups(33).   
A positive association between smoking and incident diabetes has been reported in 
several prospective cohort studies (34-38).  Collectively, these studies have 
demonstrated that persons smoking 20 or more cigarettes per day had up to a two-fold 
greater risk of developing type 2 diabetes compared to non-smokers, after adjustment 
for body mass index (BMI), alcohol consumption, physical activity and other factors(38-
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40).  Diabetes has been associated with measures of socioeconomic status such as 
poverty income ratio, education and occupational status(41-43).   
Physical activity and sedentary behaviors have been consistently associated with 
incident type 2 diabetes in both men and women (44-50).  A recent case-cohort study 
reported that increased physical activity was associated with a 13% and 7% reduction in 
diabetes risk in men and women, respectively(51).  Among women, another study found 
that for every 2 hour/day increase in time spent watching television, the risk of diabetes 
increases by 14%.  Two hour/day increases in sitting resulted in a 7% increase in 
diabetes risk.(52)  
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Cardiovascular Disease and its Relationship with Diabetes 
Chronic cardiovascular complications, also known as macrovascular complications, 
include conditions such as coronary heart disease (CHD), peripheral artery disease 
(PAD), congestive heart failure (CHF), and stroke.  Diabetes usually occurs in the 
setting of metabolic syndrome, which is comprised of abdominal obesity, hypertension, 
hyperlipidemia, hyperglycemia, and increased coagulability(53).  Although factors 
included in metabolic syndrome are also risk factors for cardiovascular disease (CVD), 
diabetes is believed to act as an independent risk factor for CVD.  
Atherosclerosis is the hardening and narrowing of the arteries and the main mechanism 
in the processes that lead to macrovascular disease.   It is also believed to be the result 
of chronic inflammation and injury to the arterial wall in the peripheral or coronary 
vascular system (53).  In response to this injury, oxidized lipids from low-density 
lipoprotein (LDL) particles accumulate in the endothelial wall of the arteries.  Monocytes 
differentiate into macrophages after infiltrating the arterial wall, and then accumulate 
oxidized lipids to create foam cells.   The foam cells promote macrophage proliferation 
and attract of T-lymphocytes.  The growing amounts of T-lymphocytes prompt smooth 
muscle proliferation in the arterial walls and collagen buildup.  This process results in 
the formation a lipid-rich atherosclerotic lesion (atheroma).(54)   
In individuals with diabetes, increased platelet adhesion and hypercoagulability occur in 
addition to the atheroma formation(54).  Increased levels of plasminogen activator 
inhibitor type 1 may also impair fibrinolysis in patients with diabetes.  Hypercoagulability 
and impaired fibrinolysis increases the risk of vascular obstruction and cardiovascular 
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events among diabetics(55).  Although the precise mechanisms are not defined, the 
association between diabetes and plaque formation is strong (54, 56).   
CVD is the leading cause of death among diabetics and CVD morbidity accounts for the 
greatest proportion of healthcare expenditures for diabetics (57, 58).  In 2010, heart 
disease and stroke were listed as contributing causes of death on 68% and 16%, 
respectively, of diabetes-related death certificates in people aged 65 years or older(20).  
In previous work conducted in the SCCS, Conway et al reported that CHD was among 
the leading causes of death among pharmaceutically-treated young-onset diabetics 
(59). Another study conducted by Conway et al among SCCS participants reported a 
greater risk of mortality among diabetics with CVD, hypertension and stroke compared 
to non-diabetics(60).   
Racial Disparities in Cardiovascular Disease and Mortality among those with Diabetes 
A systematic review of the literature published in 2005 revealed that blacks, Hispanic 
Americans, and Asian Americans had a lower risk for developing cardiovascular 
complications of diabetes compared to whites(61).  Although blacks have a lower or 
equal incidence of CVD related to diabetes, the mortality rate among blacks from CVD 
is higher(62).  The mortality difference between blacks and whites may be due, in part, 
to differences in glucose metabolism, insulin resistance, obesity, and related genetic 
factors(63). 
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CHAPTER 2 
Study Population 
All subjects for this study were participants in the SCCS, an ongoing, prospective, 
population-based study designed to examine health disparities in the incidence and 
mortality of chronic conditions.  The study population is unique, with over two-thirds 
black and both black and white participants having similar socioeconomic 
characteristics.  Details of the study design, including recruitment and sampling 
methods, were described in detail elsewhere(23).  In short, approximately 85% of 
participants were recruited from community health centers (CHCs), which are federally 
funded healthcare facilities primarily servicing low-income individuals, in 12 
southeastern states (Figure 3; Alabama, Arkansas, Florida, Georgia, Kentucky, 
Louisiana, Mississippi, North Carolina, South Carolina, Tennessee, Virginia, and West 
Virginia)(64).  CHC personnel conducted the recruitment of participants and facilitated 
the provision of informed consent.  Individuals who appeared to be 40 to 79 years of 
age were approached by CHC personnel and study eligibility was determined (age 
criterion, English-speaking, and had not undergone treatment for any cancer except 
non-melanoma skin cancer within the preceding year).(64)   
The remaining 15% of the SCCS population was recruited from the general population 
in order to provide more diversity in the income and educational backgrounds of SCCS 
participants.  Government rosters, such as driver’s license registries and Medicare 
databases, as well as organizational listings and commercial mailing files for residents 
of the study states were used for this process.  A randomly selected age-, sex-, and 
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race-stratified sample of persons aged 40-79 was contacted for potential participation.  
The sampling frame for the general population recruitment had a similar black-white 
proportion as for those recruited from CHCs, but higher percentages of whites than 
blacks were enrolled through this method.   
 
Figure 3. Locations of participating community health centers of the Southern 
Community Cohort Study (Cohen et al, 2013) 
 
Recruitment began in March 2002 and was completed in September 2009 (Table 1).  
Institutional Review Boards at Vanderbilt University Medical Center and Meharry 
Medical College have approved the study and all research protocols.  All participants 
signed written informed consent forms and since April 14, 2003, participants also signed 
Health Insurance Portability and Accountability (HIPAA) authorization forms. 
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Table 1. Characteristics of the Southern Community Cohort Study participants by sex and 
race, March 2002-September 2009 
 Black White Other race/ethnicity 
 Women Men Women Men Women Men 
N (%) 32,406 
(58.3) 
23,159 
(41.7) 
15,459 
(60.9) 
9,918 
(39.1) 
3,202  
(63.2) 
1,866 
(36.8) 
Mean age at 
enrollment (years) 
51.7 50.8 53.9 54.1 53.0 52.9 
% enrolled at 
community health 
center 
91.2 91.1 80.9 64.5 79.9 70.1 
*Adapted from The SCCS Cohort table reported at 
http://southerncommunitystudy.org/Cohort/SCCSCohort.htm. Numbers do not add up to 
100% due to rounding. 
 SCCS participants were administered a baseline questionnaire 
(http://www.southerncommunitystudy.org/InfoResearch/SCCS-questionnaire.pdf) which 
ascertained information on demographics; anthropometry; personal medical history; 
family medical history; tobacco use; medication use; reproductive history (women only); 
alcohol consumption; diet; physical activity; emotional wellness; social support; 
religion/spirituality; health insurance; use of medical and cancer screening services; 
occupational history; and other factors(23).  For CHC participants, the questionnaire 
was administered in person using a laptop computer and a computer-assisted personal 
interview (CAPI) with logic-checking and skip pattern technology.  Trained interviewers 
administered the questionnaires with the assistance of handheld cards to facilitate 
responses, and abstracted anthropometric and other clinical information (weight, height, 
blood pressure) from participants’ medical records if those measurements were also 
collected on the day of data collection. If not, the measures of height and weight were 
collected via self-report on the questionnaire.  (23, 64) General population participants 
completed and mailed in a paper version of the study questionnaire.  The paper version 
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was identical to the CAPI used at the CHCs and informed consent was obtained by a 
form included in the questionnaire booklet.  
Analyses for the association between physical activity, sedentary time, and mortality 
were conducted among all SCCS participants with diabetes who were followed through 
December 31, 2011.  The study period ended at this time because of the linkage with 
the National Death Index (NDI) was through December 31, 2011.  Participants for 
analyses of the relationship between physical activity, sedentary time, and CVD were 
selected from among SCCS participants with diabetes at cohort enrollment who are 65 
years old or greater, and thus eligible for Medicare, on or before January 1, 2008 
(“Medicare”), and/or SCCS participants with diabetes at cohort enrollment recruited in 
Tennessee under the age of 65 (“TN HDDS”).  Participants who self-reported diabetes 
(responded yes to the question “have you ever been told by a doctor that you had 
diabetes or high blood sugar or were treated for diabetes or high blood sugar?”) and 
were enrolled between March 1, 2002 and January 1, 2008 were included in the 
analyses.  The study period ended on this date because the SCCS linkage to the HDDS 
and the Medicare data was up-to-date through 2008 at the time that this study proposal 
began. As discussed later, those enrolled during 2008 may not have had sufficient 
opportunity to have a complication so additional sensitivity analyses were conducted 
including those participants to ensure the robustness of the observed estimates.  
SCCS investigators confirmed 96% of self-reported diabetes diagnoses in two validation 
studies – one reviewing medical records (n = 124) and the other evaluating A1C 
percentages(23).  For other variables self-reported at baseline (time of study 
enrollment), a series of validation studies have been conducted on subsets of the SCCS 
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population (150-800 SCCS participants) for sections of the food frequency 
questionnaire (FFQ), physical activity patterns, tobacco use, and biometric 
measurements (height/weight)(65, 66).  These validation studies reported satisfactory 
reliabilities and validities.  
Participants were included in all analyses if they were diagnosed with diabetes after the 
age of 18 years old and self-reported race as either “black” or “white”.  If participants 
were missing information regarding the age of diabetes diagnosis (“what was your age 
at first diagnosis for diabetes or high blood sugar?”), medication use (“are you currently 
taking prescription medication, including insulin, to lower your blood sugar?”), or 
demographics (age, sex, or race) they were also excluded from all analyses, as these 
variables were essential to the models constructed.  Participants were excluded from all 
analyses of CVD outcomes if they reported a history of myocardial infarction or stroke 
(heart disease) at baseline (“have you ever been told by a doctor that you had a heart 
attack…or stroke?”).  
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CHAPTER 3 
Major Cardiovascular Disease Risk among Blacks and Whites with Diabetes 
Methods 
Outcome Ascertainment 
The primary outcome measure, a composite CVD endpoint, was defined as the time 
from study enrollment to the first recorded CVD diagnosis or death with CVD as the 
primary cause or underlying cause of death (Table 2).   
Table 2. Major cardiovascular events of interest and associated diagnostic codes 
 Outcome Diagnostic Codes 
Cardiovascular Events 
(ICD-9) 
Myocardial infarction(67) 410, 411, 413, 414 
Coronary artery bypass 
surgery(68) 
36.10, 36.11, 36.12, 36.13, 36.14, 36.15, 
36.16, 36.19 (procedure codes) 
Angioplasty 36.01, 36.02, 36.05, 36.03, 36.04, 36.06, 
36.07, 36.08, 36.09 (procedure codes) 
Congestive heart failure(69) 402.01, 402.11, 402.91, and 428 
Stroke(70) 431.x, 433.x, 434.x, 436.x 
Carotid endarterectomy 38.11, 38.12 (procedure codes) 
Peripheral vascular disease 250.7, 440.x, 441.x, 442.x, 443.9, 444.x 
Fatal Cardiovascular 
Events (ICD-10) 
Myocardial infarction I21.0-I21.4, I21.9-122.1, I22.8-I23.6, I23.8 
Heart failure I11.0, I13.0, I42.0-I42.9, I50.0, I50.1, 
I50.9, I51.7 
Stroke I60.0-I60.9, I61.0-I61.9, I63.0-I63.9, I64, 
I65.0-I65.9 
Coronary artery disease I20.0, I20.8, I20.9, I21.0-I25.9, I516 
 
Non-fatal events and the date of first recorded occurrence among SCCS participants 
with diabetes who did not turn 65 on or before January 1, 2008 (“TN HDDS” group) 
were identified via the Tennessee Hospital Discharge Data System, based on 
previously validated algorithms using diagnostic (International Classification of Diseases 
Ninth Edition: ICD-9-CM) codes or the underlying cause of death on the death certificate 
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using the International Classification of Diseases Tenth Edition (ICD-10) codes used in 
previous SCCS studies on mortality among diabetics(23, 69, 71-74).  In addition to the 
composite CVD endpoint, more common events were examined individually, where the 
sample size allowed. 
The TN HDDS information became available in 1997 after the revision of Tennessee 
Code Annotate (T.C.A.), Section 68-1-108 which required each licensed hospital to 
report all claims data from the UB-92 form or any successor forms on every inpatient, 
outpatient, emergency room, or ambulatory surgery discharge to the commissioner of 
health(67). The Division of Health Statistics at the Tennessee Department of Health is 
responsible for compiling the TN HDDS on an annual basis. The UB-92 form was the 
billing form for handling health care claims until the updated UB-04 form was instituted 
in 2007.  The data for the analyses were collected using the UB-92 form.  The HDDS 
was established also for the purposes of collecting, aggregating, and disseminating 
patient level data.(67)   
At minimum, each reported discharge includes, but is not limited to, the following data 
elements: patient control number, type of bill, the period the statement covers, patient’s 
date of birth, patient’s sex, admission date, medical/health record number, revenue 
codes, date(s) of service, certificate number/identification number/social security 
number, insurance group number, principal diagnosis codes, other diagnosis codes, E 
code, principal procedure code and date, other procedure codes and date, and patient’s 
race/ethnicity(75).  Data are reported quarterly to the Tennessee Department of Health.  
Those who fail to report or report late are sent correspondence to advise of the 
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penalties associated with failure to report and are given a determined period of time to 
submit the records (76). 
The SCCS cohort was linked to the HDDS by submitting the participants’ names, dates 
of birth, and social security numbers.  The Tennessee Department of Health sent the 
returned probabilistic matches back to the International Epidemiology Institute (IEI) 
where the SCCS cohort data are housed.  IEI then evaluated the returns to confirm the 
matches by examining the dates of birth, sex, and social security number of the 
participants.  We used HDDS outcome data from March 1, 2001 through December 31, 
2008, the latest date for which such data were available when the linkage was 
performed.  Participants’ data in the TN HDDS from before their enrollment in SCCS 
were used to adjust for the previous number of cardiovascular complications 
experienced by the participant.  For each participant, the number of previous 
hospitalizations in the year prior to their study enrollment were counted and used for 
adjustment.  We limited the timeframe for the number of previous hospitalizations 
because we did not want to bias our analyses by allowing those who entered the study 
at later dates to have a longer time frame to collect previous hospitalizations compared 
to those who entered at earlier dates. We recognize that previous hospitalizations 
accrued outside of Tennessee may not have been represented in these data, and may 
have resulted in an under-adjustment for this confounding. 
CVD outcomes among SCCS participants with diabetes who turned 65 on or before 
January 1, 2008 (“Medicare” group) were ascertained by linkage, using social security 
number, date of birth, and gender, with the National Centers for Medicare and Medicaid 
Services (CMS) Research Identifiable Files from January 1, 1999 through December 
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31, 2008, the last date for which data were available.  CVD among those aged 65 years 
or older was defined as having one or more medical claims with an ICD-9 code for a 
major cardiovascular event (Table 2) within the MEDPAR (inpatient) file or two or more 
medical claims in the Medicare outpatient base claims files from the date of enrollment 
to December 31, 2008. 
Diagnosis code algorithms for the identification of major cardiovascular events were 
selected using previously validated algorithms (Table 3).  The use of diagnostic codes 
in administrative data, particularly Medicare claims data, have been reported to have a 
high positive predictive value (PPV) for the diagnosis of acute myocardial infarctions 
(ICD-9 codes 410 and 411; 69.5%-95.4%) with the inclusion of diagnosis-related group 
(DRG) codes not appreciably increasing that value(77-79).  It has also been noted that 
that the PPV was significantly lower for subjects with a history of myocardial infarction 
compared to those without previous myocardial infarctions (88.1%)(77).   A review of 
the detection of heart failure in administrative claims data included 8 studies conducted 
among Medicare beneficiaries that reported PPVs between 76% and 99%, with the 
majority of the studies reporting PPVs over 90%(80).  Among studies of hospital 
discharge records among general populations (diabetes status not specified) included in 
that review, the PPVs were similarly high (82-97%).  A similar review was conducted on 
the detection of stroke in administrative claims data and included one study conducted 
specifically among individuals ≥65 (PPV = 90%).  This review found that the studies that 
validated codes as a part of a composite endpoint reported PPVs ranging from 71% to 
96%(81). The high PPVs observed among general populations has also been observed 
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among diabetics (myocardial infarction, 95.2%; stroke, 91.2%; ischemic heart disease, 
90.3%)(82). 
In the present study, an event was counted if it was noted as the primary diagnosis, any 
of the other diagnoses (a maximum of 18 other diagnoses can be reported in the record 
for TN HDDS; a maximum of 10 can be reported in the record for Medicare), or any of 
the procedure codes (a maximum of six procedures can be reported in the record for 
both Medicare and TN HDDS).  The events were categorized dichotomously 
(present/not present). 
Deaths were ascertained through linkage of the SCCS cohort with the National Death 
Index (NDI). NDI is a national, computerized registry of all death record information on 
file in the State vital statistics offices(70).  The National Center of Health Statistics 
(NCHS) established NDI to aid medical and health research concerned with mortality 
statistics.  NDI data were available for the years from 1979 to 2011, although only 
deaths related to CVD occurring on or before December 31, 2008 were included to 
match the follow up time for incident CVD events identifiable in CMS and TN HDDS 
files.  The full period of follow-up through 2011 was used for the analyses evaluating the 
relationship between physical activity, sedentary time, and all-cause mortality.  (70, 83).  
Previous evaluations of the NDI have reported that the sensitivity of cause-specific 
death ascertainment ranged from 87% to 97% (84-86).  Sensitivity tends to vary by race 
(more sensitive for whites compared to non-whites; 93% vs. 84%), sex (more sensitive 
for males compared to female; 95% vs. 91%), and availability of social security number 
(sensitivity increases from 93% to 97%)(86).  First, ascertainment of death status was 
provided through linkage of the SCCS cohort with the Social Security Administration 
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(SSA) through February 4, 2011.  SCCS participants’ personal information was then 
linked to NDI death records through December 31, 2011 to ascertain cause of death by 
submitting an application to NCHS, thus encompassing the entire follow-up period for 
the study. To qualify as a possible match, SCCS information had to match at least one 
of seven matching criteria specified by NDI standards for each participant. (87).   
From the NDI, information on date of death, primary cause of death and contributing 
causes of death were obtained.  
Table 3. Algorithm used for the determination of a CVD event 
 Ages 
Included 
Non-Fatal CVD 
Events 
Fatal CVD 
Events 
Algorithm for Incident CVD 
“TN HDDS” 
group 
40-64 
years old 
Tennessee 
Hospital 
Discharge Data 
System (ICD-9 
codes) 
National Death 
Index 
 
≥1 discharge records with an ICD-9 
code for CVD between the date of 
enrollment and December 31, 2008 
OR 
An ICD-10 code for CVD as the 
primary or underlying cause of 
death 
“Medicare” 
group 
 
≥65 years 
old 
Medicare 
inpatient and 
outpatient files 
(ICD-9 codes) 
National Death 
Index 
Between the date of enrollment and 
December 31, 2008: 
(a) ≥1 inpatient medical 
claim(s) with an ICD-9 code 
for CVD, OR 
(b) ≥2 outpatient CVD medical 
claims with an ICD-9 code 
for CVD, OR 
(c) An ICD-10 code for CVD as 
the primary or underlying 
cause of death 
 
The person-time of follow-up began on the date of enrollment into the SCCS cohort 
(prior to January 1, 2008) and concluded with the first occurrence of a CVD event, 
death, or the end of the study period (December 31, 2008).  
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Statistical Analysis 
The HDDS data were originally in case-based form (also known as long format) where 
there were multiple observations per participant.  The dataset was converted from long 
format to wide format by reshaping.  The reshaping procedure associated the principal 
diagnosis, other diagnoses, procedures and other visit-specific information to the date of 
the admission.   For each participant, the occurrence and date of the cardiovascular 
events were determined individually.   
Prior to conducting any of the following analyses, all variables were screened for 
inconsistent or abnormal values, and continuous variables were assessed for skewness 
and outliers.  If a value appeared to be incorrectly reported (implausible), the 
observation to which the value belonged was to be removed because other measures 
for that participant may have been incorrect as well, but no observations were removed 
for those reasons. 
Proportions of the population missing data for each covariate were assessed by race.  
Reasons for missingness were examined as well (e.g. missing value for pack-years 
because participant was a non-smoker).  If the missingness was not at random, the 
observation was preserved in the dataset for analysis.  When possible the missing value 
was recoded to a non-missing value that represents the reason for missingness (e.g. 
non-smokers had their missing values recoded as 0 for pack-years and the pack-years 
for smokers were categorized in ranges).   
Descriptive statistics included counts and frequencies (or means with standard 
deviations for continuous variables) of each potential covariate by race.  The number of 
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events per category and person-time for each category by race were also calculated.  
Descriptive comparisons between black and white race, and between quartiles of 
physical activity and sedentary time, were made using Pearson’s chi-squared tests or 
ANOVA tests for categorical variables and Wilcoxon rank sum test for continuous 
variables.   
Incidence calculations and regression analyses were conducted separately for the “TN 
HDDS” group (n = 498) and the “Medicare” group (n = 1,880).  Events and person-time 
contributed by participants recruited in Tennessee who turned 65 during the study 
period were considered as a part of the “TN HDDS” group until they turned 65.  After 
that point, their events and person-time were considered under the “Medicare” group.  
Since Medicare collects data from both inpatient and outpatient medical claims, while 
TN HDDS primarily collects data from inpatient discharges, sensitivity analyses were 
conducted with only inpatient claims and discharges from both systems.  The number of 
participants who experienced a cardiovascular event during follow-up and the person-
years accrued were calculated by race.  Incidence rates were age-adjusted and 
standardized directly to the United States 2000 Census population over the age ranges 
of those over the course of follow-up. 
Unadjusted and adjusted Cox proportional hazards models, using age as the timescale, 
were specified to determine the association between race and cardiovascular events, 
generating hazards ratios (HR) and 95% confidence intervals (CI).  Those who self-
reported their race as “black” were compared to those who self-reported their race as 
“white” (referent).  The proportionality assumptions were tested for Cox proportional 
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hazards model using the goodness-of-fit testing and the log-log survival plots.  The 
results did not indicate a violation of the proportional hazards assumption. 
Unadjusted models only included cardiovascular events as the outcome and race as the 
explanatory variable (Model 1).  The minimally adjusted model added only age and sex 
as covariates (Model 2).  Model 3 added covariates selected based on the directed 
acyclic graph (DAG; see Appendix 1.1).  The DAG was constructed based on previous 
literature and biological plausibility.  A sufficient set of confounders were selected that 
close all open, backdoor pathways of the association between race and cardiovascular 
disease among SCCS participants with diabetes and represent commonly included 
confounders from similar studies.   
Such confounders considered in the multivariate analysis were BMI, education, annual 
household income, insurance status, smoking, alcohol consumption, first degree family 
history of CVD death before the age of 65, medical history (hypertension, 
hyperlipidemia, depression), previous hospitalizations in the past year, diabetes 
medication type, diabetes self-management behaviors (frequency of blood glucose 
monitoring and medication adherence) and duration of diabetes.  The number of 
covariates included in the model was limited based on the rule that a minimum of 10 
outcome events per explanatory variable may be added.   
Age and sex were chosen as variables for which the association between race and CVD 
would be adjusted because of the non-modifiable, biological differences between the old 
and the young, and males and female.  As age increases, the risk of cardiovascular 
disease increases because of vascular changes over time.  Males also are at an 
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increased risk of CVD compared to females so controlling for the biological factors that 
explain these differences is essential(88). The variables that represent differences in 
socioeconomic status between blacks and whites are necessary to include in adjusted 
models because socioeconomic status can determine healthcare access and treatment 
opportunities, as well as other factor that influence health(89). Body mass index (BMI) is 
a commonly used measure for general obesity and has also been reported as a risk 
factor for CVD.  Blacks in the SCCS are more likely to have higher BMI than whites, and 
this difference may confound the relationship between race and CVD among diabetics.  
CVD risk has been partially explained by genetic factors(90).  Including first-degree 
family history of CVD death at an early age in the adjusted models attempts to control 
for some of the confounding presented by genetic predisposition to CVD. 
Smoking was included in adjustments because it is positively associated with CVD risk 
through several established biological mechanisms and black-white differences in these 
factors have been reported.  
Hypertension and high cholesterol have been previously reported as risk factors for 
CVD and reported to be more prevalent among blacks and those of low SES(91-98). 
Hypertension also places those with diabetes at an increased risk for microvascular 
diseases such as diabetic retinopathy and renal failure (96, 99-116).  Microvascular 
disease is a risk factor in itself for cardiovascular disease (macrovascular disease) and 
is also more common among blacks with diabetes (70, 117-125). 
Diabetes has been deemed an independent risk factor for CVD so the characteristics of 
diabetes are important to adjust for in multivariate models.  The longer one has 
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diabetes, the more likely complications become (71, 126, 127).  Blacks are usually 
younger when diagnosed with diabetes and it has been proposed that the onset of 
diabetes is earlier in blacks as well (126, 128).  Based on duration of diabetes and 
glycemic control, medication is prescribed to lower blood glucose levels.  Insulin is an 
aggressive treatment for Type 2 diabetes and is associated with an increased risk of 
CVD and microvascular disease (129-132).  Insulin treatment usually occurs individuals 
with more severe diabetes or uncontrolled diabetes either alone or in concert with an 
oral medication.  Since we did not have information regarding HbA1c levels or fasting 
glucose, we used insulin and duration of diabetes as a proxy for the severity of 
diabetes.  This assumes that diabetes severity increases the longer one has the 
disease and those who use insulin have more severe diabetes. Previous SCCS studies 
have reported a higher proportion of blacks use insulin as a part of their glucose-
lowering medication(59, 60).   
Fully adjusted models included age at enrollment (years; continuous), sex, BMI (kg/m2; 
continuous), education level (less than high school, high school, beyond high school), 
annual household income (< $15,000, $15,000-49,000, and ≥ $50,000), insulin use 
(yes/no), smoking status (current, former, never), prevalent hypertension and high 
cholesterol (yes/no), parental history of CVD death (yes/no), and duration of diabetes 
(years; continuous).   
All analyses were conducted using SAS software, version 9.3 (SAS Institute Inc, Cary, 
NC) and all tests were two-sided. 
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Results 
During follow-up (median follow-up time: 4.1 years, range = 0.06-7.6 years), 362 CVD 
events or CVD-related deaths occurred in the “Medicare” group (19.3%, with 19.8% 
among blacks).  The 1,880 SCCS participants with diabetes in the “Medicare” group 
(73.7% black, 26.3% white, 70.9% female) had an average age at enrollment of 67.1 
(4.6) years (Table 4). More than 60% of the population had a high school education or 
less, and approximately 62% reported an annual household income of less than 
$15,000.  Whites were more likely to have an annual household income of $15,000 or 
more.  Higher proportions of whites than blacks had prevalent high cholesterol.  There 
were no significant differences observed in population characteristics captured at 
baseline between “TN HDDS” whites and blacks in the study. 
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Table 4. Baseline characteristics of SCCS participants with diabetes who turned 65 on 
or before January 1, 2008, by race  
 Total 
(n=1,880) 
Black 
(n=1,385) 
White 
(n=495) 
p 
Age at Enrollment  
(mean, SD) 
67.1 (4.6) 67.1 (4.7) 67.2 (4.4) 0.70 
Age at Diabetes Diagnosis  
(mean, SD) 
55.6 (10.4) 54.8 (10.6) 57.8 (9.4) <0.0001 
Time Since Diabetes Diagnosis 
(n, %) - < 5 years - 5-10 years - 11-19 years - ≥ 20 years 
 
 
691 (36.8) 
385 (20.5) 
406 (21.6) 
398 (21.2) 
 
 
471 (34.0) 
271 (19.6) 
310 (22.4) 
333 (24.0) 
 
 
220 (44.4) 
114 (23.0) 
96 (19.4) 
65 (13.1) 
 
 
<0.0001 
Female (n, %) 1,333 (70.9) 1,024 (73.9) 309 (62.4) <0.0001 
Education (n, %) - Less than High School - High School - Beyond High School 
 
881 (46.9) 
 
512 (27.2) 
487 (25.9) 
 
722 (52.1) 
 
362 (26.1) 
301 (21.7) 
 
159 (32.1) 
 
150 (30.3) 
186 (37.6) 
 
<0.0001 
 
 
Household Income (n, %) - Less than $15K - $15K-$49K - $50K or Greater 
 
1,233 (65.6) 
556 (29.6) 
91 (4.8) 
 
965 (69.7) 
378 (27.3) 
42 (3.0) 
 
268 (54.1) 
178 (36.0) 
49 (9.9) 
 
<0.0001 
Body Mass Index  
(BMI; n, %) - 18.5-24.9 - 25-29.9 - 30-39.9 - ≥ 40 
 
 
191 (10.3) 
560 (30.2) 
854 (46.1) 
249 (13.4) 
 
 
129 (9.4) 
406 (29.7) 
648 (47.4) 
183 (13.4) 
 
 
62 (12.7) 
154 (31.6) 
206 (42.2) 
66 (13.5) 
 
 
0.06 
Prevalent Conditions  
(n, %) - Hypertension - High Cholesterol 
 
 
1,608 (85.5) 
1,078 (57.4) 
 
 
1,211 (87.4) 
755 (54.6) 
 
 
397 (80.2) 
323 (65.3) 
 
 
<0.0001 
<0.0001 
Family History of CVD Death 478 (25.4) 283 (20.4) 195 (39.4) <0.0001 
Smoking Status (n, %) - Current - Former - Never 
 
247 (13.3) 
706 (37.9) 
908 (48.8) 
 
180 (13.1) 
499 (36.3) 
696 (50.6) 
 
67 (13.8) 
207 (42.6) 
212 (43.6) 
 
0.02 
Glucose-Lowering Medication  - Oral Medication Only - Insulin Use - No Medication 
 
1,142 (60.7) 
522 (27.8) 
216 (11.5) 
 
836 (60.4) 
421 (30.4) 
128 (9.2) 
 
306 (61.8) 
101 (20.4) 
88 (17.8) 
 
<0.0001 
Physical Activity  
(MET-h/d; n, %) - < 5.7 - 5.8-11.0 - 11.1-18.8 - ≥ 18.9 
 
 
397 (21.1) 
465 (24.7) 
511 (27.2) 
507 (27.0) 
 
 
302 (21.8) 
343 (24.8) 
378 (27.3) 
362 (26.1) 
 
 
95 (19.2) 
122 (24.7) 
133 (26.9) 
145 (29.3) 
 
 
0.14 
Sedentary Time 
(h/d; n, %) - < 5.2 - 5.2-7.9 - 8.0-10.6 
 
 
465 (24.7) 
485 (25.8) 
485 (25.8) 
 
 
364 (26.3) 
348 (25.1) 
352 (25.4) 
 
 
101 (20.4) 
137 (27.7) 
133 (26.9) 
 
 
0.06 
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- ≥ 10.7 445 (23.7) 321 (23.2) 124 (25.1) 
 
The overall age-adjusted rates for CVD events were 91.7 and 154.4 in the “TN HDDS” 
group and “Medicare” group, respectively.  Age-adjusted rates of CVD were similar for 
whites compared to blacks in the “TN HDDS” group but higher for whites for the 
“Medicare” group (Table 5 and Table 8). 
TABLE 5. Incidence Rates for CVD Events among Black and White SCCS Participants who 
turned 65 on or before January 1, 2008 
 
 Total Person-Years 
of Follow-Up 
CVD 
Events 
(n) 
Age-Adjusted Incidence Rate per  
1,000 Person-Years  
(95% CI) 
Black (n = 1,385) 6,023 274 142.5 (103.5-181.5) 
White (n = 495) 1,879 88 245.7 (111.9-379.6) 
Total (n = 1,880) 7,038 362 154.4 (116.6-192.2) 
 
HRs and 95% CIs for the association between race and CVD risk among those with 
diabetes in the “Medicare” group can be found in Table 6.  Blacks were at lower, but not 
significantly so, risk of CVD compared to whites (HR, 0.88; 95% CI: [0.68-1.15]).  When 
only inpatient records were considered, the results did not vary significantly (HR, 0.86; 
95% CI: [0.54-1.39]). 
TABLE 6.  Hazard ratios (95% confidence intervals) for CVD risk for blacks with diabetes 
compared to whites with diabetes in the “Medicare” group 
 # of Events Model 1 Model 2 Model 3 
Black vs. 
White Race 
362 0.96 (0.75-1.22) 0.98 (0.77-1.25) 0.88 (0.68-1.15) 
aModel 1: unadjusted; bModel 2: age at enrollment and sex; cModel3: age at enrollment, 
sex, BMI, education, annual household income, insulin use, smoking status 
(former/current/never), prevalent hypertension or high cholesterol, family history of 
premature death from myocardial infarction, and duration of diabetes. 
 
During follow-up (median follow-up time: 4.2 years, range = 0.01-7.5 years), 188 CVD 
events or CVD-related deaths occurred in the “TN HDDS” group (37.8%; 38.6% among 
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blacks and 33.7% among whites).  The 498 SCCS participants with diabetes in the “TN 
HDDS” group (83.7% black, 16.3% white, 61.9% female) had an average age at 
enrollment of 50.1 (6.2) years (Table 7). More than 60% of the population had a high 
school education or less, and 61.9% reported an annual household income of less than 
$15,000.  Whites were more likely to have an annual household income of $15,000 or 
greater and have prevalent high cholesterol.  No other significant differences in 
characteristics collected at baseline were observed between the “TN HDDS” blacks and 
whites. 
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Table 7. Baseline characteristics of SCCS participants with diabetes who were recruited 
in Tennessee at ages 40-64 years old, by race 
 Total  
(n=498) 
Black 
(n=412) 
White  
(n=86) 
p 
Age at Enrollment  
(mean, SD) 
50.1 (6.2) 50.0 (6.2) 50.5 (6.5) 0.58 
Age at Diabetes Diagnosis  
(mean, SD) 
42.7 (8.4) 42.5 (8.4) 43.8 (8.4) 0.18 
Time Since Diabetes Diagnosis 
(n, %) - < 5 years - 5-10 years - 11-19 years - ≥ 20 years 
 
 
261 (52.4) 
106 (21.3) 
91 (18.3) 
40 (8.0) 
 
 
214 (51.9) 
88 (21.4) 
74 (18.0) 
36 (8.7) 
 
 
47 (54.7) 
18 (20.9) 
17 (19.8) 
4 (4.7) 
 
 
0.63 
Female (n, %) 308 (61.9) 253 (61.4) 55 (64.0) 0.66 
Education (n, %) - Less than High School - High School - Beyond High School 
 
144 (28.9) 
 
168 (33.7) 
186 (37.4) 
 
124 (30.1) 
 
139 (33.7) 
149 (36.2) 
 
20 (23.2) 
 
29 (33.7) 
37 (43.0) 
 
0.36 
 
Household Income (n, %) - Less than $15K - $15K-$49K - $50K or Greater 
 
308 (61.9) 
163 (32.7) 
27 (5.4) 
 
254 (61.7) 
143 (34.7) 
15 (3.6) 
 
54 (62.8) 
20 (23.3) 
12 (14.0) 
 
0.0002 
Body Mass Index  
(BMI; n, %) - 18.5-24.9 - 25-29.9 - 30-39.9 - ≥ 40 
 
 
59 (11.9) 
100 (20.2) 
220 (44.5) 
115 (23.3) 
 
 
54 (13.2) 
82 (20.1) 
184 (45.1) 
88 (21.6) 
 
 
5 (5.8) 
18 (20.9) 
36 (41.9) 
27 (31.4) 
 
 
0.08 
Prevalent Conditions  
(n, %) - Hypertension - High Cholesterol 
 
 
358 (71.9) 
178 (35.9) 
 
 
300 (72.8) 
133 (32.4) 
 
 
58 (67.4) 
45 (52.3) 
 
 
0.31 
0.0005 
Family History of CVD Death 170 (34.1) 134 (32.5) 36 (41.9) 0.10 
Smoking Status (n, %) - Current - Former - Never 
 
235 (47.4) 
101 (20.4) 
160 (32.3) 
 
197 (47.9) 
85 (20.7) 
129 (31.4) 
 
38 (44.7) 
16 (18.8) 
31 (36.5) 
 
0.66 
Glucose-Lowering Medication  - Oral Medication Only - Insulin Use - No Medication 
 
270 (54.2) 
130 (30.7) 
75 (15.1) 
 
222 (53.9) 
130 (31.6) 
60 (14.6) 
 
48 (55.8) 
23 (26.7) 
15 (17.4) 
 
0.61 
Physical Activity  
(MET-h/d; n, %) - < 5.7 - 5.8-11.0 - 11.1-18.8 - ≥ 18.9 
 
 
120 (24.1) 
105 (21.1) 
100 (20.1) 
173 (34.7) 
 
 
93 (22.6) 
90 (21.8) 
86 (20.9) 
143 (34.7) 
 
 
27 (31.4) 
15 (17.4) 
14 (16.3) 
30 (34.9) 
 
 
0.30 
Sedentary Time 
(h/d; n, %) - < 5.2 - 5.2-7.9 - 8.0-10.6 
 
 
91 (18.3) 
99 (19.9) 
114 (22.9) 
 
 
78 (18.9) 
82 (19.9) 
91 (22.1) 
 
 
13 (15.1) 
17 (19.8) 
23 (26.7) 
 
 
0.74 
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- ≥ 10.7 194 (39.0) 161 (39.1) 33 (38.4) 
 
TABLE 8. Incidence rates for CVD events among black and white SCCS participants with diabetes 
who were recruited in Tennessee at ages 40-64 years old 
  
 Total Person-Years 
of Follow-Up 
CVD Events 
(n) 
Age-Adjusted Incidence Rate per  
1,000 Person-Years  
(95% CI) 
Black  
(n = 412) 
1,996 159 91.7 (68.0-115.5) 
White  
(n = 86) 
386 29 88.4 (38.6-138.3) 
Total  
(n = 498) 
2,382 188 91.1 (69.7-112.6) 
Table 9 displays the HRs and 95% CIs for the association between race and CVD risk 
among those with diabetes in the “TN HDDS” group.  Blacks did not have a significantly 
different risk of CVD compared to whites (HR, 1.01; 95% CI: [0.67-1.52]) after 
adjustment of selected covariates.  When only inpatient records (n = 97) were 
considered, blacks were at lower risk, but not significantly so (HR, 0.62; 95% CI: [0.22-
1.70]). 
Table 9. Hazard ratios (95% confidence intervals) for CVD risk for blacks with diabetes compared 
to whites with diabetes in the “TN HDDS” group 
 # of Events Model 1a Model 2b Model 3c 
Black vs. 
White Race 
188 1.12 (0.75-1.66) 1.19 (0.80-1.77) 1.01 (0.67-1.52) 
aModel 1: unadjusted; bModel 2: age at enrollment and sex; cModel3: age at enrollment, 
sex, BMI, education, annual household income, insulin use, smoking status 
(former/current/never), prevalent hypertension or high cholesterol, family history of 
premature death from myocardial infarction, and duration of diabetes. 
 
Conclusions 
The results of the current study do not support a significant association between race 
and CVD risk among individuals with diabetes. Although blacks had a higher prevalence 
of CVD risk factors like hypertension and obesity that difference did not translate into 
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increased CVD risk among that population in either the “Medicare” or “TN HDDS” group.  
Indeed, the only suggested differences were non-significantly lower mortality risks 
among blacks than whites. Diabetes itself is a strong risk factor for CVD and any racial 
differences in CVD risk may be overwhelmed by the influence of diabetes.   
Our results were consistent with other studies that reported no significant difference 
between blacks and whites with diabetes in respect to CVD risk(70).    Most of these 
studies presented condition-specific (myocardial infarction, stroke, etc.) estimates while 
our study presented risk estimates for a composite endpoint that includes CVD-related 
death.  Although our study results represented those for a composite CVD endpoint 
rather than single endpoints, the results similarly reported no increased risk of CVD 
among blacks compared to whites. 
Major strengths of the current study are the racial diversity of the sample, with blacks 
representing more than two-thirds of the study population, the systematic and 
standardized collection of extensive baseline data on the cohort participants and the 
systematic follow-up of the cohort via linkage with the Tennessee HDDS and Medicare 
files.  By design, black and white SCCS participants are of generally similar 
socioeconomic status, which allows us to evaluate risk of cardiovascular complications 
with minimal confounding presented by differences in socioeconomic factors.  We also 
have extensive information collected in our baseline in-person interview to enable 
further statistical adjustment for socioeconomic status as well as for risk factors such as 
tobacco and alcohol use, medical history, medication use, family history of chronic 
conditions, psychosocial factors, and various other characteristics of study participants. 
The current study adjusted for important confounders that have not always been 
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included in previous studies and could have a significant impact on the estimates 
generated. 
The analyses were limited by several factors.  All questionnaire data were collected at 
baseline and we do not have follow-up data for any of the covariates included in 
multivariate analyses.  Also, the questionnaire data are self-reported and may introduce 
bias.  Adjustment for covariates rendered residual confounding due to imperfect 
measurement, which is inherent to studies of this kind.  Our study relies on self-reported 
diabetes diagnosis and did not conduct chart reviews or biological testing to confirm 
diabetes in our sample population.  Previous validation studies, however, conducted 
within the SCCS using medical records for 124 participants reported that 96% of the 
self-reported diagnoses were validated using ICD-9 codes, HbA1c levels, treatment, or 
physicians’ notes(133, 134).  Therefore, we do not believe this is a significant concern in 
our study.  
We also relied on self-reported age of diagnosis and used it to determine the duration of 
diabetes in this study.  Recall errors may have caused the participant to be misclassified 
into a different duration category.  To our knowledge, no studies have validated self-
reported date or age of diabetes diagnosis but we do not believe it is a significant issue 
in our study because diabetes is a major chronic disease with significant lifestyle 
changes associated with it. However, the onset of diabetes and its symptoms may be 
gradual and date of diagnosis may not necessarily reflect date of onset.  For these 
reasons we used broad 5 and 10-year categories to group individuals by time since 
diagnosis of the condition.    
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CVD events were ascertained through hospital discharge data for the “TN HDDS” 
population, capturing only CVD events severe enough for the participant to seek care.  
However, the TN HDDS included discharges from both outpatient and ambulatory care 
departments, minimizing the potential for under-ascertainment.  Another concern 
specific to administrative billing data is that there may have been preferential coding 
since the data are intended for billing purposes and the coding is conducted by hospital 
personnel.  We do not believe that is a substantial concern in our analyses for several 
reasons. First, we took into account all of the conditions diagnosed in each admission – 
not only the principal diagnosis.  Second, there are 18 positions in which conditions can 
be coded during an admission.  In the “TN HDDS” population less than 3% of the 
participants had the 18th field completed for any of their admissions, so the majority of 
the participants had the availability of a coding position if other diagnosed conditions 
occurred during that admission.  Third, we have no reason to believe that any errors or 
prioritization in coding occurred differentially between blacks and whites. 
Our study did not have a method to definitively distinguish between type 1 and type 2 
diabetics.  In an effort to remove those likely to be type 1 diabetics, we only included 
those who reported diagnosis after 18 years of age.  We understand that all participants 
with type 1 diabetes may not have been excluded due to some participants with type 1 
diabetes being diagnosed in their early twenties.  There has been evidence of a 
biologically different type of diabetes that is usually diagnosed before age 30 with 
overlapping clinical features of both type 1 and type 2 diabetes(135).   This is an 
important limitation because these types may differ significantly in several ways (daily 
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management of the disease, duration, risk of complications).  Our estimates are not 
diabetes type-specific, but they represent the estimates for a combined group.   
The lack of evidence to support a strong racial disparity in CVD risk among those with 
diabetes reinforces the validity of managing the risk of CVD in this population, 
regardless of race.   
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Chapter 4 
Evaluation of the Independent Association between Physical Activity or 
Sedentary Time and the Risk of Cardiovascular Disease or All-Cause Mortality 
Physical Activity and Sedentary Behaviors as Risk Factors for  
Cardiovascular Complications and Mortality 
Diabetes is the seventh leading cause of death in the United States(20).  When 
compared with those without diabetes, people with diabetes have a two-fold increase in 
relative risk of death(20, 136).  Previous research conducted in SCCS reported that 
mortality risk was approximately 80% higher for those with versus without diabetes, and 
that blacks with diabetes had a slightly lower mortality risk compared with whites with 
diabetes of similarly low socioeconomic status(60).    
Strategies to reduce premature death related to diabetes have important public health 
implications. Along with self-management behaviors such as dietary alterations and 
medication adherence, healthcare providers often recommend increased physical 
activity to those with diabetes (17, 137).  Increased levels of physical activity have been 
found to increase insulin sensitivity and glucose tolerance, as well as positively impact 
serum lipid levels among individuals with type 2 diabetes(138).  A review of 47 
randomized controlled clinical trials that assessed the associations of structured 
exercise training programs that included aerobic exercise, resistance training, or both 
found that these programs were associated with a significant reduction in A1C 
levels(139).  The magnitude of these reductions has varied across studies, but it is most 
important to note that reductions have occurred and when paired with other lifestyle 
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interventions (e.g. dietary interventions), the gains in glycemic control may be magnified 
appreciably (15, 140).  
Physical activity has been historically linked with better general health and positive 
health outcomes.  According to the 2008 Physical Activity Guidelines for Americans, 
adults are recommended to engage in at least 150 minutes/week of moderate to intense 
aerobic activity to obtain health benefits and more than 300 minutes/week of aerobic 
activity to obtain further benefits(141).  The National Health Interview Survey found that 
in 2008, while 43.5% of U.S. adults could be considered active, only 28.4% of U.S. 
adults were highly active.  The United States Health and Retirement Study surveyed 
1,811 adults aged 50 years or more who responded to the 2003 Diabetes Supplement.  
They concluded that adults with diabetes who had heart disease were less likely to 
meet physical activity guidelines compared to those without heart disease (OR: 0.69; 
95% CI: 0.51-0.94)(142).   The relatively small proportion of highly active adults, and 
thus eligible to receive the extensive health benefits from that level of activity, 
demonstrated a need for more improvement in achieving increased levels of physical 
activity among Americans. 
A recent meta-analysis examined cohort studies of the association between physical 
activity and risk of all-cause mortality and CVD in patients with diabetes.  Pooled results 
from the 17 included studies reported the highest physical activity category was 
associated with lower relative risk (RR) for all-cause mortality (0.61, 95% CI: 0.52-0.70) 
and CVD (0.71, 95% CI: 0.60-0.84)(143).   The strength of the association across 
studies varies with the measure of physical activity as well as with the population, but 
the direction of the effect has been consistent among these study populations of 
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diabetics.  A majority of the aforementioned results, however, were reported among 
males, all-white populations, and populations with a low prevalence or absent of CVD 
risk factors (hypertension, obesity, hyperlipidemia, poor glycemic control).  In studies 
including both men and women, the observed effect estimates were generally not as 
strong among women with diabetes compared to men with diabetes. Not only is the 
SCCS population over two-thirds black and two-thirds female, the cohort has a high 
prevalence of CVD risk factors like obesity and hypertension. 
Diabetes may attenuate the disparity in CVD risk between males and females(144).  
Evidence exists suggesting that females with diabetes have a greater relative risk of 
CVD, CVD mortality, and ACM than males with diabetes, especially with advanced 
age(145).  This increase in risk conferred by diabetes makes physical activity as a 
strategy to decrease the risk of CVD among females even more important.  Hu et al. 
studied self-reported total physical activity, including walking, among 5,125 women with 
diabetes from the Nurses’ Health Study.  The authors reported that increased physical 
activity and walking were associated with a non-significant reduction in all CVD events 
risk (highest vs. lowest categories of activity, relative risk: 0.55; 95% CI: 0.26-1.14)(6). 
Statistically significant reductions in CVD were only observed between the second 
highest quintile of physical activity compared to the lowest quintile.  Coronary heart 
disease, pulmonary embolism, and stroke incidence were investigated in relation to self-
reported physical activity in 25,915 women with diabetes of the Million Women Study in 
the United Kingdom.  The results suggested a reduced 5-year incidence of these 
particular CVD events among active women compared to inactive women (inactive 
women HR: 2.4, 95% CI: 1.8-3.2)(146).   
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Though no published studies have presented race-specific effect estimates for the 
association between physical activity and CVD events among blacks and whites, 
several studies have included non-white participants in their study populations.  The 
previously mentioned study by Ford and colleagues also studied coronary heart disease 
mortality in conjunction with ACM.  In this 21.5% black population, leisure-time physical 
inactivity was not significantly associated with a reduction in coronary heart disease 
mortality among participants with diabetes (inactive compared to most active HR: 0.74, 
95% CI: 0.27-2.03; moderately active compared to most active HR: 0.59, 95% CI: 0.21-
1.64).  However, the previously discussed NHIS study determined that those with 
diabetes who walked at least 2 hours per week had a 34% lower CVD mortality rate 
compared to inactive participants with diabetes(5).  The width of the confidence 
intervals calculated does support the possibility of the differences in these effect 
estimates may be functions of measurement error and differences in measurement of 
physical activity, the breadth of CVD conditions included as outcomes, and the 
characteristics of each study population.  
The disparity among blacks compared to whites in the participation in leisure-time 
physical activity has been consistently reported, despite the Healthy People 2010 
recommendations (147-150).  The 2007 Behavioral Risk Factor Surveillance System 
(BRFSS) reported that non-Hispanic whites (45.7%) had a substantially greater 
proportion of highly active individuals compared with non-Hispanic blacks (37.5%) and 
Hispanics (37.6%), based on the 2008 Physical Activity Guidelines for Americans(151).  
Numerous studies suggested that socioeconomic status and environmental influence 
(e.g. access to parks and recreational centers, sidewalks, crime/community safety) play 
37 
 
   
a key role in creating and exacerbating that disparity (152-155).  Much of the research 
regarding racial differences in physical activity has been conducted among adolescents.  
One study found that black girls spent more time watching television, had higher BMIs, 
were less active, and more likely to be overweight than white girls(156).  A racially-
diverse national, longitudinal study of over 14,000 US adolescents reported that minority 
adolescents had consistently higher levels of inactivity, with females having the lowest 
levels of physical activity(157).   
An SCCS study examined the association between physical activity and sedentary time 
and BMI among black and white adult women.  The study found that among white 
women, high levels of sedentary time were strongly associated with moderate or severe 
obesity, while the association was weaker among black women(158).  The significant 
racial differences in physical activity, sedentary behaviors, and BMI among women 
suggest that the impact of activity and sedentary behaviors may vary by race. 
Sedentary lifestyles are a risk factor for overweight and obesity, and are associated with 
an increased risk of insulin resistance, CVD, and mortality (52).  Most studies estimate 
that adults spend more than half of their time sitting, doing sedentary activities (screen-
based activities like computers, television [TV] watching)(159).   Sedentary lifestyles 
have been associated with abnormal glucose metabolism and high blood glucose 
levels(47).  Time spent in sedentary behaviors is more nuanced than simply the inverse 
of physically active time.  Several studies have found independent associations 
between sedentary time and physical activity with outcomes such as obesity, abnormal 
glucose metabolism, and mortality(47). 
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Recently, a meta-analysis was conducted to examine sedentary time (primarily in TV 
viewing time) among adults and the association with diabetes, CVD and mortality.  The 
study found that increased sedentary time was associated with a 112% increase in the 
risk for diabetes (RR: 2.12, 95% CI: 1.61-2.78) and a 147% increase in CVD event risk 
(RR: 2.47, 95% CI: 1.44-2.24)(160).  This study provides support for the association 
between sedentary time and the biological process that leads to adverse outcomes.  
However, we do not yet understand fully how those who have prevalent diabetes are 
impacted by sedentary behaviors and whether the adverse effects seen in initially 
healthy populations are similar for those with diabetes. 
Methods 
The analysis was conducted separately in the “TN HDDS” group (n = 498) and the 
“Medicare” group (n = 1,880).  Participants were included in this analysis if, on the 
baseline questionnaire, they self-reported race as “black” or “white”, self-reported ever 
being diagnosed with diabetes, responded to questions regarding duration of diabetes 
and medication type, and were not missing information on body mass index, physical 
activity and sedentary time.  
Physical activity was assessed using the SCCS physical activity questionnaire (PAQ), 
which was specifically developed for the SCCS to assess physical activities at home, 
work and for leisure at enrollment during the interview (see Appendix 2).  Time spent 
conducting light, moderate, and strenuous activity at home and work were assessed for 
weekdays and weekends, both separately and combined using weighted averages.  
Interviewers asked participants about how much time the participant they spent doing 
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an activity “typically”.  Hand cards were used to assist the interviewer in showing 
examples of light work (i.e. standing at work, light office work, cooking, and child care), 
moderate work (i.e. cleaning house, gardening, and mowing lawn), and strenuous work 
(i.e. construction work or farming).  Two questions were asked about time spent doing 
moderate sports like bowling, dancing, softball, or golf, and vigorous sports like jogging, 
aerobics, bicycling, tennis, swimming, or basketball.   Sedentary time was also 
assessed in the PAQ and measured by asking the participant how much time per day 
was typically spent sitting in a car or bus, at work, watching television or movies, using a 
computer, or other sitting activities (i.e. talking on the phone, reading, or sitting at 
meals).   
Physically active times were converted from hours per day into a summary measure of 
metabolic equivalent tasks (MET) – hours per day (MET-hours/day).   MET-hours were 
chosen as the measurement of physical activity frequency and intensity because it is 
independent of weight(161).  MET values were based on the values suggested by the 
Compendium of Physical Activities(162). The exposures for the analysis were 
calculated as total physical activity (total of light, moderate, and strenuous 
household/occupational work and moderate and vigorous leisure-time physical activity 
in MET-hours/day).   
Participants were categorized by quartiles of total physical activity, in MET-hours/day, 
as calculated from the distribution among all participants that met the inclusion criteria 
for these analyses.  All sitting times were summarized into total hours per day spent in 
sedentary time. Participants were categorized in quartiles of sedentary activity as 
calculated from the distribution among all included participants.   
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Cox proportional hazards models, using age as the timescale, were constructed to 
estimate hazards ratios (HR) and 95% confidence intervals (CI) for major cardiovascular 
events in relation to total physical activity.  Models were constructed separately for total 
physical activity and sedentary time, and then adjusted for one another to determine 
whether each association is independent of the other measure.  Cohen et al.(163) 
demonstrated the independence of the sedentary time and physical activity measures in 
their recent report relating those two metrics to breast cancer risk in the SCCS cohort.  
In particular, they showed that, among cases and controls, sedentary time was not 
simply the inverse of physically active time.  Also, when models with physical activity as 
the exposure variable were adjusted for total sedentary time, the confidence intervals 
for the estimates remained consistent and did not widen substantially.(164) Thus, we 
have considered total activity and total sedentary time as independent measures related 
to CVD.   
Unadjusted models included only physical activity or sedentary time.  Minimally adjusted 
models added age and sex only.  Fully adjusted model (Model A) included age, sex, 
and selected covariates.  Fully adjusted (Model B) added physical activity or sedentary 
time, as appropriate, to the model.  Variables considered in the DAG of the association 
between physical activity and the risk of major cardiovascular events were based on 
previous literature and biological plausibility (see Appendix 1.2). Such confounders 
considered in the multivariate analysis are BMI, education, annual household income, 
insurance status, smoking, alcohol consumption, first degree family history of CVD 
death before the age of 65, total energy intake, medical history (hypertension, 
hyperlipidemia, microvascular disease, and depression), medication type, other 
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medication use (statins, anti-hypertensive medications, and aspirin), and duration of 
diabetes.   
To explore the possibility of reverse causation, whereby decreased levels of physical 
activity in some participants may be due to illness, secondary analyses excluding 
participants who died within the first year of follow-up were conducted.  Decreased The 
results were compared for similarity in the magnitude and the direction of the effect.   
Age and sex were chosen as variables for which the association between physical 
activity and CVD, and sedentary time and CVD, were adjusted.  The variables that 
represented differences in socioeconomic status between those who are active and 
those who are less active are necessary to include in adjusted models because 
socioeconomic status can determine healthcare access and treatment opportunities, as 
well as other factor that influence health(89). SES also strongly ties together 
neighborhood structure and ability to be physically active.  Low SES neighborhoods are 
more likely to have higher crime rates and a built environment not conducive to regular, 
outdoor exercise (149, 152, 154, 165).  
Smoking behavior for those who are active versus those who are not active may differ.  
Usually, those who participate in healthy behaviors such as physical activity may also 
be less likely to smoke or may have quit smoking (166, 167).   
Hypertension may place those with diabetes at an increased risk for microvascular 
diseases such as diabetic retinopathy and renal failure (96, 99-116).  Vigorous physical 
activity can have a negative impact on diabetic retinopathy and is sometimes 
contraindicated in those with hypertension (168, 169).  Therefore, those individuals may 
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be among the less active individuals who are at an increased risk of CVD. High 
cholesterol is a risk factor for CVD and physical activity is often suggested to those with 
high cholesterol in addition to treatment.  Those with high cholesterol may be more 
physically active, due to those recommendations, and those who are not active would 
be at an increased risk of CVD incidence and death.  Including high cholesterol in the 
models as a covariate will adjust for the possible differences in risk that may exist 
between those with and without the condition. 
Full models were adjusted for age at enrollment, sex and race (except for in race- and 
sex-specific analyses), body mass index (kg/m2, continuous), educational attainment 
(less than high school, high school graduate, beyond high school), annual household 
income (< $15, $15-$50K, >$50K), insulin use (yes/no), smoking (current, former, 
never), family history of premature CVD-related death (yes/no), hypertension, high 
cholesterol, duration of diabetes, and physical activity or sedentary time.   
All analyses were conducted using SAS software, version 9.3 (SAS Institute, Cary, NC) 
and all tests were two-sided. 
Results 
During follow-up (median follow-up time: 4.1 years, range = 0.06-7.6 years), 362 CVD 
events or CVD-related deaths occurred among the 1,880 participants in the “Medicare” 
group (19.3%, with 19.8% among blacks and 17.8% among whites; 18.6% among 
females; 20.8% among males) (Tables 10 and 11). Table 12 shows the HRs (95% CI) 
for CVD risk across quartiles of physical activity in the SCCS cohort participants with 
diabetes in the “Medicare” group, overall and stratified by race. Increased physical 
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activity was not significantly associated with CVD (highest vs. lowest quartile: HR, 0.92; 
95% CI: 0.67-0.1.25).  The highest level of physical activity corresponds to doing 
moderate exercise for one hour, five days per week. These associations were not 
significantly different for blacks and whites (p-for interaction by race = 0.75), or for 
women and men (p-for interaction by sex = 0.61). The estimates did not appreciably 
change when participants who died within the first year of follow-up were excluded 
(highest compared with lowest level of physical activity, HR 0.90; 95% CI: 0.66-1.23). 
Table 13 shows HRs (95% CIs) for the association between quartiles of sedentary time 
and CVD, overall and stratified by race in the “Medicare” group.  Sedentary time in the 
highest quartile corresponds to spending more than half of the 24-hour day or ¾ of 
usual waking hours (16 hours) in sedentary behaviors.   Among participants with 
diabetes, those in the highest quartile of sedentary time had a non-significantly higher 
CVD risk than those in the lowest quartile (HR, 1.21; 95% CI 0.89-1.64).  Race-specific 
analyses showed that these results did not differ significantly among blacks compared 
to whites (p-for interaction by race = 0.18), although a significant trend of increasing risk 
with increasing sedentary time was observed among whites.  Similarly, sex did not 
modify the association between sedentary time and CVD risk (p-for interaction by sex = 
0.27), but a significant trend of rising risk with rising sedentary time was observed 
among women. The estimates did not appreciably change when participants who died 
within the first year of follow-up were excluded (highest compared with lowest level of 
sedentary time, HR 1.19; 95% CI: 0.87-1.62). 
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Table 10. Baseline characteristics of SCCS participants with diabetes in the “Medicare” 
group by Physical Activity Quartiles 
 Physical 
Activity 
< 5.7 
MET-hr/d 
(n=397) 
Physical 
Activity 
5.7-11.0 
MET-hr/d 
(n=465) 
Physical 
Activity 
11.1-18.8 
MET-hr/d 
(n=511) 
Physical 
Activity  
≥ 18.9 
MET-hr/d 
(n=507) 
p 
Age at Enrollment 
 (years; mean, SD) 
68.3 (5.1) 67.0 (4.6) 67.0 (4.4) 66.5 (4.4) <0.0001 
Race (n, %) 
- Black 
- White 
 
302 (76.1) 
95 (23.9) 
 
343 (73.8) 
122 (26.2) 
 
378 (74.0) 
133 (26.0) 
 
362 (71.4) 
145 (28.6) 
 
0.14 
Age at Diabetes Diagnosis  
(years; mean, SD) 
55.5 (11.2) 55.6 (10.0) 55.4 (10.4) 55.8 (10.1) 0.95 
Female (n, %) 242 (61.0) 343 (73.8) 371 (72.6) 377 (74.4) <0.0001 
Education 
- Less than High School 
- High School Graduate 
- Beyond High School 
 
221 (55.7) 
100 (25.2) 
76 (19.1) 
 
217 (46.7) 
136 (29.3) 
112 (24.1) 
 
235 (46.0) 
130 (25.4) 
146 (28.6) 
 
208 (41.0) 
146 (28.8) 
153 (30.2) 
 
<0.0001 
Annual Household Income (n,%) 
- Less than $15K 
- $15-49K 
- $50K or Greater 
 
 
296 (74.6) 
94 (23.7) 
7 (1.8) 
 
 
325 (69.9) 
119 (25.6) 
21 (4.5) 
 
 
308 (60.3) 
169 (33.1) 
34 (6.7) 
 
 
304 (60.0) 
174 (34.3) 
29 (5.7) 
 
 
<0.0001 
Body Mass Index (n, %; kg/m2) 
- Normal (18.5-24.9) 
- Overweight (25-29.9) 
- Obese (30-39.9) 
- Severely Obese (40+) 
 
 
38 (9.7) 
115 (29.4) 
178 (45.5) 
60 (15.4) 
 
 
35 (7.7) 
128 (28.1) 
220 (48.4) 
72 (15.8) 
 
 
64 (12.7) 
148 (29.3) 
235 (46.5) 
58 (11.5) 
 
 
54 (10.7) 
169 (33.6) 
221 (43.9) 
59 (11.7) 
 
 
0.009 
Time since Diabetes Diagnosis 
(years) 
-  0-5 years 
-  6-10 years 
- 11-19 years 
- 20+ years 
 
 
129 (32.5) 
82 (20.7) 
87 (21.9) 
99 (24.9) 
 
 
166 (35.7) 
106 (22.8) 
98 (21.1) 
95 (20.4) 
 
 
192 (37.6) 
93 (18.2) 
120 (23.5) 
106 (20.7) 
 
 
204 (40.2) 
104 (20.5) 
101 (19.9) 
98 (19.3) 
 
 
0.014 
Glucose-Lowering Medication  - Oral Medication Only - Insulin Use - No Medication 
 
230 (57.9) 
127 (32.0) 
40 (10.1) 
 
294 (63.2) 
125 (26.9) 
46 (9.9) 
 
300 (58.7) 
150 (29.4) 
61 (11.9) 
 
318 (62.7) 
120 (23.7) 
69 (13.6) 
 
0.006 
Comorbidity History (n, %) 
- Hypertension 
- High Cholesterol 
 
345 (86.9) 
209 (52.6) 
 
404 (86.9) 
259 (55.8) 
 
435 (85.1) 
306 (59.9) 
 
424 (83.6) 
304 (60.2) 
 
0.11 
0.011 
Smoking History (n, %) 
- Current 
- Former 
- Never 
 
59 (14.9) 
146 (36.9) 
191 (48.2) 
 
82 (17.8) 
174 (37.7) 
206 (44.6) 
 
58 (11.6) 
192 (38.3) 
251 (50.1) 
 
48 (9.6) 
194 (38.7) 
260 (51.8) 
 
0.006 
Parental History of MI (n, %) 87 (21.9) 116 (25.0) 140 (27.4) 135 (26.6) 0.08 
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 Table 11. Baseline characteristics of SCCS participants with diabetes in the “Medicare” group by 
Sedentary Time Quartiles 
 Sedentary 
Time  
< 5.25 h/d 
(n=465) 
Sedentary 
Time  
5.25-7.9 h/d 
(n=485) 
Sedentary 
Time 
8.0-10.6 h/d 
(n=485) 
Sedentary 
Time 
≥ 10.7 h/d 
(n=445) 
p 
Age (years; mean, SD) 67.5 (4.8) 67.3 (4.7) 67.0 (4.5) 66.7 (4.5) 0.06 
Race (n, %) 
- Black 
- White 
 
364 (78.3) 
101 (21.7) 
 
348 (71.8) 
137 (28.3) 
 
352 (72.6) 
133 (27.4) 
 
321 (72.1) 
124 (27.9) 
 
0.06 
Age at Diabetes Diagnosis 
(years; mean, SD) 
55.8 (10.4) 55.4 (10.6) 55.9 (10.0) 55.2 (10.5) 0.75 
Female (n, %) 335 (72.0) 335 (69.1) 358 (73.8) 305 (68.5) 0.57 
Annual Household Income (n,%) 
- Less than $15K 
- $15-49K 
- $50K or Greater 
 
 
341 (73.3) 
108 (23.2) 
16 (3.4) 
 
 
301 (62.1) 
154 (31.8) 
30 (6.2) 
 
 
321 (66.2) 
140 (28.9) 
24 (5.0) 
 
 
270 (60.7) 
154 (34.6) 
21 (4.7) 
 
 
0.003 
Education 
- Less than High School 
- High School Graduate 
- Beyond High School 
 
267 (57.4) 
111 (23.9) 
87 (18.7) 
 
210 (43.3) 
151 (31.1) 
124 (25.6) 
 
229 (47.2) 
128 (26.4) 
128 (26.4) 
 
175 (39.3) 
122 (27.4) 
148 (33.3) 
 
<0.0001 
Body Mass Index (n, %; kg/m2) 
- Normal (18.5-24.9) 
- Overweight (25-29.9) 
- Obese (30-39.9) 
- Severely Obese (40+) 
 
58 (12.7) 
134 (29.3) 
205 (44.8) 
61 (13.3) 
 
49 (10.2) 
163 (34.0) 
206 (42.9) 
62 (12.9) 
 
50 (10.5) 
133 (28.0) 
229 (48.2) 
63 (13.3) 
 
34 (7.7) 
130 (29.5) 
214 (48.5) 
63 (14.3) 
 
0.03 
Time since Diabetes Diagnosis 
(years) 
-  0-5 years 
-  6-10 years 
- 11-19 years 
- 20+ years 
 
 
174 (37.4) 
87 (18.7) 
101 (21.7) 
103 (22.2) 
 
 
172 (35.5) 
100 (20.6) 
108 (22.3) 
105 (21.7) 
 
 
184 (37.9) 
101 (20.8) 
99 (20.4) 
101 (20.8) 
 
 
161 (36.2) 
97 (21.8) 
98 (22.0) 
89 (20.0) 
 
 
0.98 
Glucose-Lowering Medication  - Oral Medication Only - Insulin Use - No Medication 
 
294 (63.2) 
130 (28.0) 
41 (8.8) 
 
285 (58.8) 
142 (29.3) 
58 (12.0) 
 
289 (59.6) 
132 (27.2) 
64 (13.2) 
 
274 (61.6) 
118 (26.5) 
53 (11.9) 
 
0.43 
Comorbidity History (n, %) 
- Hypertension 
- High Cholesterol 
 
409 (88.0) 
261 (56.4) 
 
409 (84.3) 
281 (57.9) 
 
412 (85.0) 
257 (53.0) 
 
378 (84.9) 
279 (62.8) 
 
0.39 
0.02 
Smoking History (n, %) 
- Current 
- Former 
- Never 
 
47 (10.3) 
161 (35.2) 
250 (54.6) 
 
55 (11.4) 
182 (37.8) 
244 (50.7) 
 
74 (15.3) 
188 (38.9) 
221 (45.8) 
 
71 (16.2) 
175 (39.9) 
193 (44.0) 
 
0.01 
Parental History of MI (n, %) 103 (22.2) 130 (26.8) 122 (25.2) 123 (27.6) 0.23 
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Table 12. Hazard Ratios (95% Confidence Intervals) for the association between quartiles of total physical activity 
and CVD risk among SCCS participants with diabetes in the “Medicare” group 
 Unadjusted Minimally 
Adjusted 
HR (95% CI) 
Model A 
HR (95% CI) 
Model B 
Total (MET-h/d; n = 1,880) - < 5.7 - 5.8-11.0 - 11.1-18.8 - ≥ 18.9 
 
Reference 
0.95 (0.71-1.28) 
0.78 (0.58-1.05) 
0.90 (0.67-1.20) 
 
Reference 
0.94 (0.69-1.26) 
0.76 (0.56-1.03) 
0.87 (0.64-1.17) 
 
Reference 
1.01 (0.75-1.37) 
 0.79 (0.58-1.09) 
0.95 (0.70-1.29) 
 
Reference 
1.01 (0.74-1.36) 
   0.77 (0.56-1.06) 
0.93 (0.68-1.26) 
p-for trend 0.29 0.21 0.44 0.33 
Black (MET-h/d; n = 1,385)  - < 5.7 - 5.8-11.0 - 11.1-18.8 - ≥ 18.9 
 
Reference 
0.98 (0.70-1.38) 
0.83 (0.59-1.18) 
0.93 (0.66-1.31) 
 
Reference 
0.97 (0.69-1.38) 
0.82 (0.58-1.17) 
0.93 (0.66-1.31) 
 
Reference 
1.08 (0.76-1.54) 
0.88 (0.61-1.27) 
1.01 (0.71-1.45) 
 
Reference 
1.08 (0.76-1.54) 
0.88 (0.61-1.27) 
1.01 (0.71-1.45) 
p-for trend 0.50 0.49 0.77 0.76 
White (MET-h/d; n = 495) - < 5.7 - 5.8-11.0 - 11.1-18.8 - ≥ 18.9 
 
Reference 
0.86 (0.47-1.56) 
0.63 (0.34-1.17) 
0.79 (0.44-1.40) 
 
Reference 
0.88 (0.47-1.63) 
0.65 (0.34-1.21) 
0.71 (0.40-1.29) 
 
Reference 
0.85 (0.45-1.59) 
0.55 (0.28-1.08) 
0.67 (0.36-1.24) 
 
Reference 
0.86 (0.46-1.62) 
0.53 (0.26-1.05) 
0.64 (0.34-1.20) 
p-for trend 0.32 0.19 0.13 0.10 
Males (MET-h/d; n = 547)  - < 5.7 - 5.8-11.0 - 11.1-18.8 - ≥ 18.9 
 
Reference 
0.93 (0.57-1.50) 
0.66 (0.39-1.10) 
0.70 (0.42-1.17) 
 
Reference 
0.89 (0.55-1.45) 
0.64 (0.39-1.07) 
0.67 (0.40-1.07) 
 
Reference 
0.99 (0.60-1.63) 
0.63 (0.36-1.09) 
0.75 (0.43-1.29) 
 
Reference 
1.00 (0.60-1.65) 
0.64 (0.37-1.11) 
0.76 (0.44-1.31) 
p-for trend 0.08 0.06 0.13 0.15 
Females (MET-h/d; n = 1,333) - < 5.7 - 5.8-11.0 - 11.1-18.8 - ≥ 18.9 
 
Reference 
1.03 (0.70-1.51) 
0.89 (0.61-1.31) 
1.06 (0.73-1.53) 
 
Reference 
0.98 (0.67-1.44) 
0.85 (0.57-1.25) 
0.98 (0.67-1.43) 
 
Reference 
1.05 (0.71-1.55) 
0.89 (0.60-1.32) 
1.06 (0.72-1.57) 
 
Reference 
1.07 (0.72-1.58) 
0.89 (0.60-1.32) 
1.05 (0.71-1.54) 
p-for trend 0.92 0.99 0.94 0.96 
  
47 
 
   
Table 13. Hazard ratios (95% confidence intervals) for the association between quartiles of total sedentary time 
and CVD risk among SCCS participants with diabetes in the “Medicare” group 
 Unadjusted Minimally 
Adjusted 
HR (95% CI) 
Model A 
HR (95% CI) 
Model B 
Total (h/d; n = 1,880) - < 5.2 - 5.2-7.9 - 8.0-10.6 - ≥ 10.7 
 
Reference 
1.05 (0.78-1.42) 
1.23 (0.92-1.64) 
1.21 (0.90-1.62) 
 
Reference 
1.05 (0.78-1.41) 
1.23 (0.92-1.65) 
1.17 (0.87-1.58) 
 
Reference 
1.05 (0.77-1.43) 
1.21 (0.89-1.63) 
1.20 (0.88-1.63) 
 
Reference 
1.05 (0.77-1.43) 
1.21 (0.89-1.63) 
1.21 (0.89-1.64) 
p-for trend 0.13 0.18 0.17 0.16 
Black (h/d; n = 1,385)  - < 5.2 - 5.2-7.9 - 8.0-10.6 - ≥ 10.7 
 
Reference 
1.00 (0.72-1.39) 
1.05 (0.76-1.46) 
1.02 (0.72-1.42) 
 
Reference 
1.00 (0.72-1.39) 
1.06 (0.77-1.48) 
1.00 (0.71-1.40) 
 
Reference 
0.97 (0.69-1.36) 
1.03 (0.74-1.45) 
1.03 (0.73-1.46) 
 
Reference 
0.97 (0.69-1.36) 
1.03 (0.74-1.45) 
1.04 (0.74-1.48) 
p-for trend 0.85 0.92 0.80 0.76 
White (h/d; n = 495) - < 5.2 - 5.2-7.9 - 8.0-10.6 - ≥ 10.7 
 
Reference 
1.57 (0.73-3.36) 
2.46 (1.20-5.04) 
2.46 (1.20-5.06) 
 
Reference 
1.53 (0.71-3.28) 
2.24 (1.09-4.62) 
2.22 (1.08-4.57) 
 
Reference 
1.69 (0.76-3.77) 
2.33 (1.08-5.03) 
2.36 (1.07-5.04) 
 
Reference 
1.71 (0.77-3.81) 
2.33 (1.08-5.04) 
2.36 (1.09-5.12) 
p-for trend 0.005 0.02 0.02 0.02 
Males (h/d; n = 547)  - < 5.2 - 5.2-7.9 - 8.0-10.6 - ≥ 10.7 
 
Reference 
0.81 (0.48-1.37) 
1.25 (0.76-2.07) 
0.83 (0.49-1.40) 
 
Reference 
0.82 (0.48-1.39) 
1.25 (0.75-2.07) 
0.80 (0.47-1.35) 
 
Reference 
0.84 (0.48-1.47) 
1.29 (0.76-2.18) 
0.85 (0.78-1.49) 
 
Reference 
0.84 (0.48-1.47) 
1.29 (0.76-2.18) 
0.85 (0.49-1.50) 
p-for trend 0.88 0.76 0.007 0.004 
Females (h/d; n = 1,333) - < 5.2 - 5.2-7.9 - 8.0-10.6 - ≥ 10.7 
 
Reference 
1.18 (0.82-1.71) 
1.24 (0.86-1.78) 
1.42 (0.99-2.04) 
 
Reference 
1.18 (0.82-1.71) 
1.23 (0.86-1.76) 
1.40 (0.97-2.00) 
 
Reference 
1.17 (0.80-1.70) 
1.20 (0.83-1.74) 
1.38 (0.95-2.00) 
 
Reference 
1.16 (0.80-1.69) 
1.20 (0.83-1.74) 
1.39 (0.96-1.74) 
p-for trend 0.06 0.08 0.013 0.008 
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During follow-up (median follow-up time: 4.2 years, range = 0.01-7.5 years), 188 CVD 
events or CVD-related deaths occurred in the “TN HDDS” group (37.8%; 38.6% among 
blacks and 33.7% among whites).  The 498 SCCS participants with diabetes in the “TN 
HDDS” group (83.7% black, 16.3% white, 61.9% female) had an average age at 
enrollment of 50.1 (6.2) years (Tables 14 and 15).  
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Table 14. Baseline characteristics of SCCS participants with diabetes in the “TN HDDS” 
group by Physical Activity Quartiles 
 Physical 
Activity 
<5.7  
MET-hr/d 
(n = 120) 
Physical 
Activity 
5.7-11.4 
MET-hr/d 
(n = 105) 
Physical 
Activity 
11.5-19.9 
MET-hr/d 
(n = 100) 
Physical 
Activity  
≥20.0 
MET-hr/d 
(n = 173) 
p 
Age at Enrollment 
 (years; mean, SD) 
50.8 (6.0) 52.0 (6.3) 49.9 (6.2) 48.6 (6.0) <0.0001 
Race (n, %) 
- Black 
- White 
 
93 (77.5) 
27 (22.5) 
 
90 (85.7) 
15 (17.4) 
 
86 (86.0) 
14 (14.0) 
 
143 (82.7) 
30 (17.3) 
 
0.30 
Age at Diabetes Diagnosis  
(years; mean, SD) 
42.6 (8.8) 44.5 (8.0) 42.2 (8.2) 42.0 (8.4) 0.25 
Female (n, %) 63 (52.5) 70 (66.7) 67 (67.0) 108 (62.4) 0.08 
Education 
- Less than High School 
- High School Graduate 
- Beyond High School 
 
36 (30.0) 
39 (32.5) 
45 (32.5) 
 
41 (39.1) 
33 (31.4) 
31 (29.5) 
 
25 (25.0) 
35 (34.0) 
40 (40.0) 
 
42 (24.3) 
61 (35.3) 
70 (40.5) 
 
0.21 
Annual Household Income (n,%) 
- Less than $15K 
- $15-49K 
- $50K or Greater 
 
95 (79.2) 
23 (19.2) 
2 (1.7) 
 
71 (67.6) 
30 (28.6) 
4 (3.8) 
 
52 (52.0) 
40 (40.0) 
8 (8.0) 
 
90 (52.0) 
70 (40.5) 
13 (7.5) 
 
<0.0001 
Body Mass Index  
(n, %; kg/m2) 
- Normal (18.5-24.9) 
- Overweight (25-29.9) 
- Obese (30-39.9) 
- Severely Obese (40+) 
 
 
17 (14.4) 
20 (17.0) 
48 (40.7) 
33 (28.0) 
 
 
16 (15.4) 
19 (18.3) 
46 (44.2) 
23 (22.1) 
 
 
7 (7.0) 
23 (23.0) 
48 (48.0) 
22 (22.0) 
 
 
19 (11.1) 
38 (22.1) 
78 (45.4) 
37 (21.5) 
 
 
0.59 
Time since Diabetes Diagnosis 
(years) 
-  0-5 years 
-  6-10 years 
- 11-19 years 
- 20+ years 
 
 
59 (49.2) 
28 (23.3) 
19 (15.8) 
14 (11.7) 
 
 
50 (47.6) 
24 (22.9) 
25 (23.8) 
6 (5.7) 
 
 
54 (54.0) 
14 (14.0) 
22 (22.0) 
10 (10.0) 
 
 
98 (56.7) 
40 (23.1) 
25 (14.5) 
10 (5.8) 
 
 
0.16 
Glucose-Lowering Medication  - Oral Medication Only - Insulin Use - No Medication 
 
63 (52.5) 
44 (36.7) 
13 (10.8) 
 
57 (54.3) 
34 (32.4) 
14 (13.3) 
 
61 (61.0) 
24 (24.0) 
15 (15.0) 
 
89 (51.5) 
51 (29.5) 
33 (19.1) 
 
0.26 
Comorbidity History (n, %) 
- Hypertension 
- High Cholesterol 
 
88 (73.3) 
43 (35.8) 
 
80 (76.2) 
43 (41.0) 
 
74 (74.0) 
36 (36.4) 
 
116 (67.1) 
56 (32.6) 
 
0.35 
0.57 
Smoking History (n, %) 
- Current 
- Former 
- Never 
 
61 (51.7) 
23 (19.5) 
34 (28.8) 
 
55 (52.4) 
25 (23.8) 
25 (23.8) 
 
45 (45.0) 
18 (18.0) 
37 (37.0) 
 
74 (42.8) 
35 (20.2) 
64 (37.0) 
 
0.28 
Parental History of MI (n, %) 49 (40.8) 34 (32.4) 26 (26.0) 61 (35.3) 0.13 
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Table 15. Baseline characteristics of SCCS participants with diabetes in the “TN HDDS” 
group by Sedentary Time Quartiles 
 Sedentary 
Time 
< 5.5 h/d 
(n = 91) 
Sedentary 
Time 
5.5-7.9 h/d 
(n = 99) 
Sedentary 
Time 
8.0-10.9 h/d 
(n = 114) 
Sedentary 
Time 
≥ 11.0 h/d 
(n = 194) 
p 
Age at Enrollment 
 (years; mean, SD) 
49.7 (6.1) 50.7 (6.6) 49.8 (6.2) 50.2 (6.1) 0.72 
Race (n, %) 
- Black 
- White 
 
78 (85.7) 
13 (14.3) 
 
82 (82.8) 
17 (17.2) 
 
91 (79.8) 
23 (20.2) 
 
161 (83.0) 
33 (17.0) 
 
0.74 
Age at Diabetes Diagnosis  
(years; mean, SD) 
43.0 (8.1) 43.7 (9.0) 41.8 (8.4) 42.6 (8.3) 0.42 
Female (n, %) 53 (53.5) 53 (64.9) 74 (64.9) 128 (66.0) 0.15 
Education 
- Less than High School 
- High School Graduate 
- Beyond High School 
 
32 (35.2) 
32 (35.2) 
27 (29.7) 
 
33 (33.3) 
29 (29.3) 
37 (37.4) 
 
37 (32.5) 
38 (33.3) 
39 (34.2) 
 
42 (21.7) 
58 (35.6) 
83 (42.8) 
 
0.12 
Annual Household Income (n,%) 
- Less than $15K 
- $15-49K 
- $50K or Greater 
 
 
59 (64.8) 
30 (33.0) 
2 (2.2) 
 
 
67 (67.7) 
28 (28.3) 
4 (4.0) 
 
 
78 (68.4) 
31 (27.2) 
5 (4.4) 
 
 
104 (53.6) 
74 (38.1) 
16 (8.3) 
 
 
0.06 
Body Mass Index (n, %; kg/m2) 
- Normal (18.5-24.9) 
- Overweight (25-29.9) 
- Obese (30-39.9) 
- Severely Obese (40+) 
 
 
12 (13.3) 
24 (26.7) 
31 (34.4) 
23 (25.6) 
 
 
13 (13.3) 
22 (22.5) 
50 (51.0) 
13 (13.3) 
 
 
18 (15.9) 
23 (20.4) 
53 (46.9) 
19 (16.8) 
 
 
16 (8.3) 
31 (16.1) 
86 (44.6) 
60 (31.1) 
 
 
0.008 
Time since Diabetes Diagnosis 
(years) 
-  0-5 years 
-  6-10 years 
- 11-19 years 
- 20+ years 
 
 
48 (52.8) 
22 (24.2) 
13 (14.3) 
8 (8.8) 
 
 
57 (57.6) 
17 (17.2) 
19 (19.2) 
6 (6.1) 
 
 
57 (50.0) 
28 (24.6) 
15 (13.2) 
14 (12.3) 
 
 
99 (51.0) 
39 (20.1) 
44 (22.7) 
12 (6.2) 
 
 
0.27 
Glucose-Lowering Medication  - Oral Medication Only - Insulin Use - No Medication 
 
52 (57.1) 
25 (27.5) 
14 (15.4) 
 
51 (51.5) 
28 (28.3) 
20 (20.2) 
 
56 (49.1) 
40 (35.1) 
18 (15.8) 
 
111 (57.2) 
60 (30.9) 
23 (11.9) 
 
0.49 
Comorbidity History (n, %) 
- Hypertension 
- High Cholesterol 
 
63 (69.2) 
29 (31.9) 
 
69 (69.7) 
37 (37.4) 
 
87 (76.3) 
42 (36.8) 
 
139 (71.7) 
70 (36.5) 
 
0.64 
0.85 
Smoking History (n, %) 
- Current 
- Former 
- Never 
 
53 (58.9) 
11 (12.2) 
26 (28.9) 
 
43 (43.9) 
28 (28.6) 
27 (27.6) 
 
52 (45.6) 
22 (19.3) 
40 (35.1) 
 
87 (44.9) 
40 (20.6) 
67 (34.5) 
 
0.09 
Parental History of MI (n, %) 32 (35.2) 36 (36.4) 33 (29.0) 69 (35.6) 0.61 
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Table 14 shows the HRs (95% CI) for CVD risk across quartiles of physical activity in 
the SCCS cohort participants with diabetes in the “TN HDDS” group, overall and 
stratified by race. Increased physical activity was not significantly associated with CVD 
(highest vs. lowest quartile: HR, 0.82; 95% CI: 0.55-0.1.22).  The highest level of 
physical activity corresponds to doing moderate exercise for approximately one hour, 
five days per week. Table 15 shows HRs (95% CIs) for the association between 
quartiles of sedentary time and CVD, overall and stratified by race.  Sedentary time in 
the highest quartile corresponds to spending more than half of the 24-hour day or ¾ of 
usual waking hours (16 hours) in sedentary behaviors.   Among participants with 
diabetes, those in the highest quartile of sedentary time did not have a significantly 
different CVD risk than those in the lowest quartile (HR, 0.75; 95% CI 0.50-1.13).  For 
both physical activity and sedentary time, the sample size was not sufficient to conduct 
race- or sex-specific analyses. 
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Table 16. Hazard ratios (95% confidence intervals) for the association between quartiles of total physical activity 
and CVD risk among SCCS participants with diabetes in the “TN HDDS” group 
 Unadjusted Model Minimally 
Adjusted 
HR (95% CI) 
Model A 
HR (95% CI) 
Model B 
Total (MET-h/d; n = 498) - < 5.7 - 5.8-11.4 - 11.5-19.9 - ≥ 20.0 
 
Reference 
1.08 (0.73-1.61) 
0.79 (0.52-1.22) 
0.66 (0.45-0.97) 
 
Reference 
1.02 (0.69-1.53) 
0.85 (0.55-1.31) 
0.75 (0.51-1.11) 
 
Reference 
1.07 (0.71-1.62) 
 1.00 (0.63-1.58) 
0.90 (0.60-1.34) 
 
Reference 
1.02 (0.68-1.54) 
  0.92 (0.59-1.45) 
0.82 (0.55-1.22) 
p-for trend 0.01 0.10 0.53 0.28 
 
 
 Table 17. Hazard ratios (95% confidence intervals) for the association between quartiles of total sedentary time 
and CVD risk among SCCS participants with diabetes in the “TN HDDS” group 
 Unadjusted Minimally 
adjusted 
HR (95% CI) 
Model A 
HR (95% CI) 
Model B 
Total (h/d; n = 498) - < 5.5 - 5.5-7.9 - 8.0-10.9 - ≥ 11.0 
 
Reference 
0.69 (0.44-1.08) 
0.82 (0.54-1.25) 
0.75 (0.51-1.09) 
 
Reference 
0.65 (0.41-1.02) 
0.79 (0.52-1.20) 
0.72 (0.49-1.05) 
 
Reference 
0.67 (0.42-1.07) 
0.69 (0.44-1.07) 
0.75 (0.50-1.13) 
 
Reference 
0.67 (0.42-1.08) 
0.68 (0.44-1.06) 
0.75 (0.50-1.13) 
p-for trend 0.28 0.23 0.31 0.29 
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Conclusions 
The principal findings of this study were that, overall, neither increased levels of 
physical activity nor increased sedentary time was significantly associated with CVD risk 
among those with diabetes, both in the younger “TN HDDS” group and the older 
“Medicare” group.  In subgroup analyses, a significant association between increased 
sedentary time and CVD risk was observed among whites in the “Medicare” group (HR, 
2.36; 95% CI: [1.09-5.12]), with a significant dose-response trend.  No other race or 
gender groups exhibited similar associations or trends. 
In the SCCS, black and white adults reporting the highest levels of total physical activity 
and the least sedentary time had a reduced risk of CVD mortality(170). Cohen et al 
examined physical activity in relation to breast cancer risk in the SCCS female 
population.  The final models showed physical activity had an inverse association and 
sedentary behavior a positive association with breast cancer risk among white women 
only(163).  The current study adds to the information available from the SCCS 
population regarding the role of physical activity and sedentary time in the risk of CVD. 
Since we do not know the exact mechanisms and lead times associated with the 
physical activity-CVD relationship studied here, we did not know if participants had 
enough of an opportunity to experience a physical activity protective event. We do not 
have information on how long the participants have been as active as they reported at 
enrollments and we do not know the period of time necessary for physical activity to 
impact CVD risk. For those enrolled later in the study period, the cumulative likelihood 
of observing an event (but not necessarily the spontaneous hazard rate) is reduced 
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because the time in which to observe the event is reduced.  Except as noted previously 
for those enrolled in the SCCS in 2008, all participants had at least a year of follow-up.   
For our main exposure variables, total physical activity and total sedentary time, some 
participants in our analyses reported total hours spent in physical activity or sedentary 
time in excess of 24 hours (n = 1,547).  Since participants were asked about individual 
activity or sitting times and their responses were not confined to the 24-hour day, we 
could not reliably determine which individual times were over-reported. Due to our 
categorization of total physical activity and total sedentary time into quartiles, the 
participants who over-reported would largely be contained in the highest quartiles of 
activity or sitting, where they would arguably belong even in the absence of over-
reporting.  
Additionally, the possibility of reverse causation exists in prospective cohort studies of 
this kind.  Those who are less physically active may be ill in some other way, which may 
make them more likely to experience a fatal or non-fatal event during the follow-up 
period.  We attempted to control for this potential bias by conducting secondary 
analyses excluding participants who died within the first year of follow-up.  Excluding 
these participants may leave us with the healthier participants thus biasing our results.  
However, we do not believe this exclusion are of significant concern because the  
results of those analyses did not differ significantly from that of the main analyses. 
Our studies did not observe a significant, causal relationship between physical activity, 
sedentary time, and CVD in the two cohorts studied.  However, given the small sample 
size we used in these analyses, we suggest this study be improved among a larger, 
racially-diverse, and mixed-gender population with diabetes. 
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CHAPTER 5 
Effect Modification of the Association between Physical Activity or Sedentary 
Time and Cardiovascular Disease by Body Mass Index 
Obesity as a Risk Factor for Cardiovascular Complications 
Obesity is an epidemic in the United States with the age-adjusted prevalence of 
overweight and obesity being 68% among both men and women (NHANES 1998-
2008)(171).  Obesity has been implicated as a risk factor for numerous adverse health 
conditions from cancer to heart disease to diabetes.   
An early study concluded that obesity in type 2 diabetics was not associated with 
increased risk for incident cardiovascular complications when compared to normal 
weight (HR: 0.66, 95% CI: 0.56-0.78)(172). This study introduced the idea of an obesity 
paradox in the relationship to diabetes-related complications - an inverse relationship 
between BMI and risk, especially among populations with traditional risk factors for 
CVD.  Additional recent studies have also reported the apparent obesity paradox, 
including a study examining the association between weight status and mortality in 
diabetics using separate and pooled data from the Atherosclerosis Risk in Communities 
(ARIC) study, Cardiovascular Health Study (CHS), Coronary Artery Risk Development 
in Young Adults (CARDIA) study, Framingham Offspring Study (FOS), and Multi-Ethnic 
Study of Atherosclerosis (MESA)(173).  This pooled study included subgroup analysis 
by race (non-white versus white) and reported that the obesity paradox was more 
pronounced among non-whites compared to whites, but the difference did not reach 
significance.   
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Since the inverse relationship between BMI and mortality is not intuitive, reviews and 
commentaries have been published attempting to explain the paradox.  One paper that 
focused on the obesity paradox among patients with heart failure suggested that the 
obese patients used in the studies that reported the paradox may be healthier than their 
non-obese comparators, the measures of body mass index may not be accurate, 
cachexia due to other illnesses (wasting syndrome) may be responsible, or the 
association may be different in the severely obese who have not been studied (174).  
Another review urged researchers to consider using other indices of body fat distribution 
(e.g. waist circumference, waist-to-hip ratio) instead of BMI because studies that used 
BMI reported the obesity paradox, whereas in studies that used other measures of body 
fatness, obesity was directly and positively associated with higher event rates and total 
mortality compared to normal weight(175).  Though the evidence for and against the 
existence of the obesity paradox is controversial, the evidence against the paradox has 
not been reported among those with diabetes and the race-specific pertinence has not 
been well-established. 
Of note, the studies that have identified the obesity paradox may be explained by the 
methods in regression modeling and the causal pathway.  First, obesity is a risk factor 
for hypertension and hyperlipidemia (high cholesterol).  Both of those conditions are risk 
factors for CVD.  The studies examining the relationship between obesity and CVD are 
often adjusted for these conditions that may be on the causal pathway to CVD.  
Adjusting for these conditions can remove the effects of the very mechanism that would 
connect obesity and CVD.   
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Blacks are more likely to be overweight or obese compared to whites, and obesity may 
also affect diabetes risk through different mechanisms (176-178). Multivariate analyses 
have shown that race remains to be an independent risk factor for obesity, even after 
adjustment for socioeconomic status and other covariates like age and sex15,182,183.  In 
the SCCS cohort, 83% of black females were in overweight or obese BMI categories 
(BMI > 25) compared to 75% of white females(33).   The differences observed between 
women are often hypothesized to be due to the cultural idealization of thinness and the 
perception of attractiveness related to thinness among whites(179).  Sociocultural 
standards may influence racial differences in obesity, but genetic studies have found 
evidence that obesity may be hereditary.  A recent genetic study discovered three new 
loci in the human genome distinctly related to BMI in individuals of African ancestry 
(180).  These unique loci may help explain the racial differences observed in BMI 
between blacks and whites.   
The association between physical activity and CVD may differ across BMI levels.  High 
levels of physical activity have been shown to attenuate the risk of obesity at a genetic 
level through early to late adulthood(181).  Additionally, those in the normal BMI 
category are more likely to attain a higher level of cardiorespiratory fitness compared to 
obese individuals(182).  Several studies have reported an inverse relationship between 
cardiorespiratory fitness and CVD risk(3, 15, 169).  One study performed maximal 
exercise tests on 2,316 male participants from the ACLS and studied CVD mortality 
among several BMI strata.  This study found that low cardiorespiratory fitness was 
associated with an increased risk of CVD mortality within all weight categories (normal 
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weight: HR: 2.7, 95% CI: 1.3-5.7; overweight: HR: 2.7, 95% CI: 1.4-5.1; obese: HR: 2.8, 
95% CI: 1.4-5.1)(3).  
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Methods 
Physical activity was assessed using the SCCS physical activity questionnaire as 
previously described.  BMI was calculated from participants’ self-reported height and 
weight values.  BMI was modeled in the continuous format for the analysis and 
categorized for display. Participants were categorized as normal weight (BMI between 
18.5 kg/cm2 and less than 25 kg/cm2; referent), overweight (BMI between 25 kg/cm2 and 
less than 30 kg/cm2), obese (BMI between 30 kg/cm2 and less than 40 kg/cm2), and 
severely obese (BMI greater or equal to 40 kg/cm2).  
Adjusted Cox proportional hazards models were used to generate hazard ratios and 
95% CIs for the association between BMI and CVD risk among the “Medicare” group.  
The interaction between physical activity and body mass index was assessed by the 
inclusion of an interaction term to the final adjusted model for the physical activity-CVD 
association conducted among the “Medicare” group.  The interaction was comprised of 
the categorical physical activity variable and the BMI variable in its continuous form.  
Models with and without the physical activity and body mass index interaction term were 
compared using likelihood ratio tests (LRT).  Similarly, an interaction term was created 
for sedentary time and BMI then entered into the final adjusted model for the sedentary 
time-CVD association conducted among the “Medicare” group.  Interactions were 
considered significant if LRT was significant at the 0.05 level.   
All analyses were conducted using SAS software, version 9.3 (SAS Institute Inc, Cary, 
NC) and all tests were two-sided. 
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Results 
Of the 1,880 participants with diabetes in the “Medicare” group, the majority were 
considered in the obese or severely obese category (58.7%; Table 19).  Obese and 
severely obese participants were significantly younger at enrollment and at the time of 
diabetes diagnosis.  Those who were severely obese were more likely to be female, 
have prevalent hypertension, be less active, never have smoked, and use insulin as a 
part of their diabetes treatment regimen.  There were no significant differences in racial 
composition or socioeconomic status between those in each of the BMI categories.   
We examined CVD risk in relation to BMI and observe no significantly different risks in 
the obese categories compared to the normal weight category of those with diabetes 
(obese: HR: 0.82, 95% CI: 0.57-1.19; severely obese: HR: 0.90, 95% CI: 0.58-1.40).  
There was not a significant interaction between BMI and physical activity levels (p-for 
interaction = 0.77).  A significant interaction was also not observed between BMI and 
sedentary time (p-for interaction = 0.33). 
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Table 18. Baseline characteristics of SCCS participants with diabetes aged 65 years or more 
(2002-2008) by Body Mass Index Categories 
 BMI  
Normal 
(n = 186) 
BMI 
Overweight 
(n = 560) 
BMI 
Obese 
(n = 854) 
BMI  
Severely 
Obese 
(n = 249) 
p 
Age at Enrollment  
(years; mean, SD) 
68.4 (5.0) 67.6 (4.7) 66.8 (4.5) 66.0 (4.3) <0.0001 
Race (n, %) 
- Black 
- White 
 
125 (67.2) 
61 (32.8) 
 
406 (72.5) 
154 (27.5) 
 
648 (75.9) 
206 (24.1) 
 
183 (73.5) 
66 (26.5) 
 
0.10 
Age at Diabetes Diagnosis 
(years; mean, SD) 
57.2 (10.3) 56.4 (10.2) 55.4 (10.5) 53.5 (10.1) 0.002 
Female (n, %) 115 (61.8) 352 (62.9) 623 (73.0) 217 (87.2) <0.0001 
Education 
- Less than High School 
- High School Graduate 
- Beyond High School 
 
77 (41.4) 
59 (31.7) 
50 (26.9) 
 
261 (46.6) 
146 (26.1) 
153 (27.3) 
 
405 (47.4) 
228 (26.7) 
221 (25.9) 
 
120 (48.2) 
72 (28.9) 
57 (22.96) 
 
0.52 
Household Income (n, %) - Less than $15K - $15K-$49K - $50K or Greater 
 
119 (64.0) 
57 (30.7) 
10 (5.4) 
 
352 (62.9) 
169 (30.2) 
39 (7.0) 
 
565 (66.2) 
252 (29.5) 
37 (4.3) 
 
172 (69.1) 
72 (28.9) 
5 (2.0) 
 
0.09 
Time since Diabetes Diagnosis 
(years) 
-  0-5 years 
-  6-10 years 
- 11-19 years 
- 20+ years 
 
 
72 (38.7) 
40 (21.5) 
37 (19.9) 
37 (19.9) 
 
 
218 (38.9) 
118 (21.1) 
99 (17.7) 
125 (22.3) 
 
 
321 (37.6) 
164 (19.2) 
198 (23.2) 
171 (20.0) 
 
 
72 (28.9) 
54 (21.7) 
68 (27.3) 
55 (22.1) 
 
 
0.06 
Comorbidity History (n, %) 
- Hypertension 
- High Cholesterol 
 
138 (74.2) 
99 (53.2) 
 
474 (84.6) 
337 (60.2) 
 
741 (86.8) 
481 (56.5) 
 
227 (91.2) 
145 (58.5) 
 
<0.0001 
0.29 
Glucose-Lowering Medication  - Oral Medication Only - Insulin Use - No Medication 
 
113 (60.8) 
42 (22.6) 
31 (16.7) 
 
360 (64.3) 
133 (23.8) 
67 (31.8) 
 
512 (60.0) 
253 (29.6) 
89 (10.4) 
 
138 (55.4) 
87 (34.9) 
24 (9.6) 
 
0.0009 
Smoking History (n, %) 
- Current 
- Former 
- Never 
 
37 (20.2) 
69 (37.7) 
77 (42.1) 
 
81 (14.7) 
217 (39.3) 
254 (46.0) 
 
103 (12.2) 
327 (38.6) 
418 (49.3) 
 
20 (8.1) 
85 (34.4) 
142 (57.5) 
 
0.0007 
Parental History of MI (n, %) 46 (24.7) 132 (23.6) 211 (24.7) 76 (30.5) 0.20 
Total Physical Activity  
(MET-hrs/day) 
- < 5.7 
- 5.8-11.0 
- 11.1-18.8 
- ≥ 18.9 
 
 
37 (19.9) 
34 (18.3) 
63 (33.9) 
52 (28.0) 
 
 
115 (20.5) 
128 (22.9) 
148 (26.4) 
169 (30.2) 
 
 
178 (20.8) 
220 (25.8) 
235 (27.5) 
221 (25.9) 
 
 
60 (24.1) 
72 (28.9) 
58 (23.3) 
59 (23.7) 
 
 
0.08 
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Conclusions 
Our study did not observe the inverse relationship between BMI and CVD risk as seen 
in previous studies.  The independent associations between physical activity, sedentary 
time, and CVD risk were not modified by BMI.  The results of our study add to the 
continuing conversation about obesity, physical activity, and CVD.  Church et al 
examined the risk of CVD by BMI and cardiorespiratory fitness levels(3).  Obese (BMI > 
30 kg/cm2) individuals with diabetes in the moderate and high fit group were statistically 
at no higher risk for CVD mortality compared to those of normal weight and similar 
fitness levels.  This finding is consistent with that of our current study. A study of male 
veterans with diabetes also found similar physical activity-CVD relationships across BMI 
categories that were specified similar to our study (8).   
BMI may not be the correct metric by which to examine this relationship.  BMI as a 
measure of general obesity has been disputed and other metrics, such as waist-to-hip 
ratio and waist circumference, have often been promoted as measures that better 
correlate to adverse outcomes(183-185).  Future research should explore these 
analyses with better studied measures like the aforementioned and even investigate 
other measures or supplements that would better model the obesity-CVD association.  
Further, the interaction between obesity and physical activity levels can be better 
studied using more precise and objective measures of activity.  Acceleration-based 
measures may give us a greater understanding of a participant’s actual average activity 
level across a time period rather than relying on reported information.   
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This study was limited by certain factors.  BMI was calculated from self-reported values 
of height and weight.  Poor reporting of weight and height has been consistently 
reported as being differential between races and genders (186).  Studies have noted 
that severely obese women of lower socioeconomic status tended to underreport their 
height and weight.  Older people tend to over-report their height and more accurately 
report their weight(187).  These differential errors in self-reporting may have caused 
misclassification of participants and biased our studies.   
Additionally, given that BMI was calculated at enrollment and we did not update their 
height and weight measurements within this study, changes in BMI may have impacted 
participants’ risk of CVD.  However, we do not believe this to be as much an issue 
because BMI is not as sensitive as a weight measurement and fluctuations in weight 
would need to be quite significant in order to change BMI considerably.   
Obesity, while a risk factor for diabetes and CVD, did not impact the relationship 
between physical activity and CVD.   
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CHAPTER 6 
The Independent Associations between Physical Activity and Sedentary Time 
with All-Cause Mortality among Low-Income Adults with Diabetes 
Methods 
The primary outcome was defined as death from any cause.  Vital status and date of 
death were ascertained through linkage of the SCCS cohort with the Social Security 
Administration (SSA) vital status service for epidemiologic researchers and  the National 
Death Index (NDI) through December 31, 2011(60).   
Person-years of follow-up began on the date of enrollment into the SCCS cohort and 
concluded on the date of death or the end of the study period (December 31, 2011), 
whichever came first.  Descriptive statistics for the study population were calculated, 
including means and standard deviations for continuous variables as well as counts and 
percentages for categorical or dichotomous variables.  Values for each quartile of 
physical activity were compared using chi-squared tests and one-way ANOVA tests.   
Cox proportional hazards models, using age as the time scale, were constructed to 
estimate hazards ratios (HR) and 95% confidence intervals (CI) for mortality in relation 
to total physical activity and total sedentary time, first separately and then mutually 
adjusted to determine whether the associations were independent of each other. Fully 
adjusted models included age at enrollment, race (black or white; not included in race-
stratified models), sex (not included in sex-stratified models), body mass index (BMI; 
18-24.9, 25-29.9, 30-39.9, ≥40 kg/m2), educational attainment (less than high school, 
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high school graduate, beyond high school), annual household income (< $15, $15-
$50K, >$50K), insulin use (yes/no), smoking (current, former, never), hypertension, high 
cholesterol, or cardiovascular disease (myocardial infarction/bypass and stroke) 
prevalent at baseline (all yes/no), and duration of diabetes (years). The dose-response 
trend for total physical activity or total sedentary time was evaluated by entering the 
ordinal form of the variable into a proportional hazards model with death as the 
outcome.  The p-value for the likelihood ratio test was used to assess the trend for total 
physical activity or sedentary time. 
Sensitivity analyses were conducted to evaluate the potential effect of exposure outliers 
for physical activity and sedentary time, and to exclude those who died in the first year 
of follow-up to mitigate the possibility of reverse causation.  To test whether outlier 
values for physical activity and sedentary time impacted estimates, a term ((physical 
activity outlier: yes or no; sedentary time outlier: yes or no) was added to the models in 
sensitivity analyses to determine whether adjusting for the distribution of those outliers 
would appreciably change the estimates. To assess whether those with pre-existing 
conditions that increased their risk of death outside of physical activity or sedentary time 
exposure, we conducted another sensitivity analysis where those who died in the first 
year of follow-up were excluded.  To explore whether physical activity and sedentary 
time jointly influence mortality, we examined the joint effects for these exposures using 
tertiles.  All analyses were conducted using Stata software, version 11 (StataCorp LP, 
College Station, TX) and all tests were two-sided. 
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Results 
The 15,645 SCCS participants with diabetes (71.2% black, 28.8% white, 65.0% female) 
had an average age at enrollment of 54.9 (8.9) years (Table 16).  Approximately two-
thirds of the population had a high school education or less, and more than 60% 
reported an annual household income of less than $15,000.  Blacks were slightly 
younger than whites at both their time of enrollment and time of diabetes diagnosis.  
Whites were more likely to have obtained a high school education or beyond.  A higher 
proportion of whites than blacks were also in the severely obese (BMI ≥ 40) category 
and reported prevalent CVD at baseline.  Blacks reported slightly but significantly higher 
total physical activity levels than whites and had higher proportions of individuals in both 
the highest and lowest categories of sedentary time.  Blacks were more likely to never 
have smoked.  Of note, blacks were also significantly more likely to use insulin as a part 
of their diabetes medication regimen than were whites. 
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Table 19. Baseline characteristics of SCCS participants with diabetes by race and sex 
 Total 
(n=15,645) 
Black 
(n=11,137) 
White 
(n=4,508) 
p Male 
(n=5,483) 
Female 
(n=10,162) 
p 
Age at Enrollment  
(mean, SD) 
54.9 (8.9) 54.4 (8.8) 56.0 (8.9) <0.0001 54.6 (8.7) 55.1 (8.9) 
 
<0.001 
Age at Diabetes Diagnosis  
(mean, SD) 
46.1 (10.5) 45.4 (10.4) 47.8 (10.8) <0.0001 46.3 (10.2) 47.3 (10.9) 0.10 
Time Since Diabetes Diagnosis 
(n, %) - < 5 years - 5-10 years - 11-19 years - ≥ 20 years 
 
 
6,284 (40.2) 
4,407 (28.2) 
3,019 (19.3) 
1,935 (12.4) 
 
 
4,368 (39.2) 
3,094 (27.8) 
2,214 (19.9) 
1,461 (13.1) 
 
 
1,916 (42.5) 
1,313 (29.1) 
805 (17.9) 
474 (10.5) 
 
 
<0.0001 
 
 
2,228 (40.6) 
1,638 (29.9) 
1,056 (19.3) 
561 (10.2) 
 
 
4,056 (39.9) 
2,769 (27.3) 
1,963 (19.3) 
1,374 (13.5) 
 
 
0.06 
Female (n, %) 10,162 (65.0) 7,290 (65.5) 2,872 (63.7) 0.04 ------ -----  
Black Race (n, %) 
Education (n, %) - Less than High School - High School - Beyond High School 
11,137 (71.2) 
 
5,374 (34.4) 
 
5,049 (32.3) 
5,219 (33.4) 
------ 
 
4,067 (36.5) 
 
3,535 (31.8) 
3,530 (31.7) 
------ 
 
1,307 (29.0) 
 
1,514 (33.6) 
1,686 (37.4) 
 
 
<0.0001 
3,847 (70.2) 
 
1,861 (34.0) 
 
1,770 (32.3) 
1,849 (33.7) 
7,290 (71.7) 
 
3,513 (34.6) 
 
3,279 (32.3) 
3,367 (33.1) 
 
 
 
0.68 
Household Income (n, %) - Less than $15K - $15K-$49K - $50K or Greater 
 
9,391 (60.8) 
5,124 (33.2) 
940 (6.1) 
 
6,908 (62.8) 
3,604 (32.8) 
492 (4.5) 
 
2,483 (55.8) 
1,520 (34.2) 
448 (10.1) 
 
<0.0001 
 
2,961 (54.7) 
1,950 (36.1) 
498 (9.2) 
 
6,430 (64.0) 
3,174 (31.6) 
442 (4.4) 
 
<0.0001 
Body Mass Index  
(BMI; n, %) - 18.5-24.9 - 25-29.9 - 30-39.9 - ≥ 40 
 
 
1,662 (10.8) 
3,655 (23.6) 
6,991 (45.2) 
3,155 (20.4) 
 
 
1,244 (11.3) 
2,663 (24.2) 
4,959 (45.1) 
2,137 (19.4) 
 
 
418 (9.4) 
992 (22.2) 
2,032 (45.6) 
1,018 (22.8) 
 
 
<0.0001 
 
 
872 (16.0) 
1,669 (30.7) 
2,301 (42.3) 
602 (11.1) 
 
 
790 (7.9) 
1,986 (19.8) 
4,690 (46.8) 
2,553 (25.5) 
 
 
<0.0001 
Prevalent Conditions  
(n, %) - Hypertension - High Cholesterol - Heart Attack/Bypass - Stroke/TIA 
 
 
12,432 (79.5) 
8,644 (55.4) 
2,095 (13.4) 
1,722 (11.0) 
 
 
9,009 (80.9) 
5,738 (51.6) 
1,231 (11.1) 
1,183 (10.6) 
 
 
3,423 (76.0) 
2,906 (64.7) 
864 (19.2) 
539 (12.0) 
 
 
<0.0001 
<0.0001 
<0.0001 
0.02 
 
 
4,287 (78.2) 
2,930 (53.6) 
948 (17.3) 
633 (11.6) 
 
 
8,145 (80.2) 
5,714 (56.3) 
1,147 (11.3) 
1,089 (10.7) 
 
 
0.004 
0.001 
<0.0001 
0.12 
Smoking Status (n, %) - Current  4,553 (29.2)  3,267 (29.5)  1,286 (28.7)  <0.0001  2,013 (37.0)  2,540 (25.1)  <0.0001 
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- Former - Never 4,591 (29.5) 6,418 (41.2) 3,050 (27.5) 4,768 (43.0) 1,541 (34.4) 1,650 (36.9)  1,939 (35.6) 1,490 (27.4) 2,652 (26.2) 4,928 (48.7) 
Glucose-Lowering Medication  - Oral Medication Only - Insulin Use - No Medication 
 
8,769 (56.1) 
4,445 (28.4) 
2,431 (15.5) 
 
6,265 (56.3) 
3,351 (30.1) 
1,521 (13.7) 
 
2,504 (55.6) 
1,094 (24.3) 
910 (20.2) 
 
<0.0001 
 
 
2,975 (54.3) 
1,598 (29.2) 
906 (16.5) 
 
5,790 (57.0) 
2,847 (28.0) 
1,525 (15.0) 
 
 
0.003 
Physical Activity  
(MET-h/d; n, %) - < 6.9 - 6.9-14.1 - 14.2-24.8 - ≥ 24.9 
 
 
3,822 (24.4) 
4,002 (25.6) 
3,908 (25.0) 
3,913 (25.0) 
 
 
2,648 (23.8) 
2,830 (25.4) 
2,811 (25.2) 
2,848 (25.6) 
 
 
1,174 (26.0) 
1,172 (26.0) 
1,097 (24.3) 
1,065 (23.6) 
 
 
0.004 
 
 
1,714 (31.3) 
1,218 (22.2) 
1,085 (19.8) 
1,466 (26.7) 
 
 
2,108 (20.7) 
2,784 (27.4) 
2,823 (27.8) 
2,447 (24.1) 
 
 
<0.001 
Sedentary Time 
(h/d; n, %) - < 6 - 6-8.4 - 8.5-11.9 - ≥ 12.0 
 
 
3,801 (24.3) 
3,822 (24.4) 
3,647 (23.3) 
4,375 (28.0) 
 
 
2,784 (25.0) 
2,656 (23.9) 
2,569 (23.1) 
3,128 (28.1) 
 
 
1,017 (22.6) 
1,166 (25.9) 
1,078 (23.9) 
1,247 (27.7) 
 
 
0.002 
 
 
1,289 (23.5) 
1,323 (24.1) 
1,236 (22.5) 
1,635 (29.8) 
 
 
2,512 (24.7) 
2,499 (24.6) 
2,411 (23.7) 
2,740 (27.0) 
 
 
0.002 
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During follow-up (median follow-up time: 6.2 years, range = 0.01-9.8 years), 2,370 
deaths (15.2%, with similar percentages among blacks and whites; 12.3% among 
females; 20.4% among males) occurred among the study population for a crude annual 
death rate of 2.44%.  Table 17 shows the HRs (95% CI) for mortality across quartiles of 
physical activity in the SCCS cohort participants with diabetes, overall and stratified by 
race and by sex. Increased physical activity was inversely associated with mortality in a 
dose-response manner (highest vs. lowest quartile: HR, 0.64; 95% CI: 0.56-0.72).  The 
highest level of physical activity corresponds to doing moderate exercise for one hour, 
five days per week. These associations were not significantly different for blacks and 
whites (p-for interaction by race = 0.19), or for women and men (p-for interaction by sex 
= 0.93). The estimates did not appreciably change when participants who died within 
the first year of follow-up were excluded (results not shown; highest compared with 
lowest level of physical activity, HR 0.65; 95% CI: 0.57-0.74). 
Table 18 shows HRs (95% CIs) for the association between quartiles of sedentary time 
and mortality, overall and stratified by race and by sex.  Sedentary time in the highest 
quartile corresponds to spending more than half of the 24-hour day or ¾ of usual 
waking hours (16 hours) in sedentary behaviors.   Among participants with diabetes, 
those in the highest quartile of sedentary time had mortality risk approximately 25% 
higher than those in the lowest quartile (HR, 1.25; 95% CI 1.11-1.40), with a significant 
dose-response trend.  Race-specific analyses showed that high levels of sedentary time 
were associated with similarly increased mortality risk among blacks and whites (p-for 
interaction by race = 0.29).  Similarly, sex did not modify the association between 
sedentary time and mortality (p-for interaction by sex = 0.83).  
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Analysis of the joint effects of physical activity and sedentary time on mortality (Figure 
4) showed that individuals who were the most sedentary (≥11 h/d) and the least active 
(< 9 MET-h/d) were at the greatest risk of death (HR 1.80, 95% CI: 1.50-2.16) compared 
to other physical activity-sedentary time categories. 
  
71 
 
   
Table 20. Hazard Ratios (95% Confidence Intervals) for the association between quartiles of total 
physical activity and all-cause mortality risk among SCCS participants with diabetes 
 Person-
Years 
# 
Events 
HR (95% CI)a HR (95% CI)b 
Total (MET-h/d; n = 15,645) - < 6.9 - 6.9-14.1 - 14.2-24.8 - ≥ 24.9 
 
22,004 
24,050 
24,275 
24,245 
 
887 
591 
466 
426 
 
Reference 
0.76 (0.68 – 0.85) 
0.65 (0.58 – 0.73) 
0.65 (0.57 – 0.73) 
 
Reference 
0.76 (0.68 – 0.84) 
0.65 (0.57 – 0.73) 
0.64 (0.56 – 0.72) 
p-for trend   < 0.0001 < 0.0001 
Black (MET-h/d; n = 11,137)  - < 6.9 - 6.9-14.1 - 14.2-24.8 - ≥ 24.9 
 
15,780 
17,578 
18,067 
18,368 
 
601 
428 
332 
324 
 
Reference 
0.81 (0.71 – 0.92) 
0.68 (0.59 – 0.78) 
0.70 (0.61 – 0.81) 
 
Reference 
0.81 (0.71 – 0.92) 
0.67 (0.58 – 0.77) 
0.69 (0.60 – 0.79) 
p-for trend   < 0.0001 < 0.0001 
White (MET-h/d; n = 4,508) - < 6.9 - 6.9-14.1 - 14.2-24.8 - ≥ 24.9 
 
6,224 
6,472 
6,208 
5,877 
 
286 
163 
134 
102 
 
Reference 
0.65 (0.53 – 0.79) 
0.62 (0.50 – 0.77) 
0.54 (0.43 – 0.69) 
 
Reference 
0.65 (0.53 – 0.80) 
0.62 (0.50 – 0.77) 
0.54 (0.43 – 0.69) 
p-for trend   < 0.0001 < 0.0001 
Males (MET-h/d; n = 5,483)  - < 6.9 - 6.9-14.1 - 14.2-24.8 - ≥ 24.9 
 
9,473 
7,045 
6,573 
8,772 
 
497 
240 
182 
199 
 
Reference 
0.77 (0.66 – 0.90) 
0.66 (0.56 – 0.79) 
0.65 (0.54 – 0.77) 
 
Reference 
0.77 (0.65 – 0.89) 
0.66 (0.55 – 0.79) 
0.64 (0.54 – 0.76) 
p-for trend   < 0.0001 < 0.0001 
Females (MET-h/d; n = 10,162) - < 6.9 - 6.9-14.1 - 14.2-24.8 - ≥ 24.9 
 
12,531 
17,005 
17,702 
15,473 
 
390 
351 
284 
227 
 
Reference 
0.75 (0.65 – 0.88) 
0.64 (0.55 – 0.76) 
0.65 (0.55 – 0.77) 
 
Reference 
0.75 (0.65 – 0.87) 
0.64 (0.55 – 0.75) 
0.64 (0.54 – 0.75) 
p-for trend   < 0.0001 < 0.0001 
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Table 21. Hazard Ratios (95% Confidence Intervals) for the association between quartiles of total 
sedentary time and all-cause mortality risk among SCCS participants with diabetes 
 Person-
Years 
# Events HR (95% CI)a HR (95% CI)b 
Total (h/d; n = 15,645) - < 6 - 6 – 8.4 - 8.5 – 11.9 - ≥ 12 
 
23,162 
23,263 
22,025 
26,124 
 
562 
589 
542 
677 
 
Reference 
1.03 (0.92 – 1.16) 
1.11 (0.99 – 1.26) 
1.23 (1.10 – 1.38) 
 
Reference 
1.04 (0.92 – 1.17) 
1.13 (1.00 – 1.27) 
1.25 (1.11 – 1.40) 
p-for trend   <0.0001 <0.0001 
Black (h/d; n = 11,137)  - < 6  - 6 – 8.4  - 8.5 – 11.9  - ≥ 12  
 
17,608 
16,731 
16,080 
19,374 
 
422 
413 
386 
464 
 
Reference 
1.00 (0.87 – 1.15) 
1.11 (0.97 – 1.28) 
1.17 (1.02 – 1.34) 
 
Reference 
1.01 (0.88 – 1.16) 
1.13 (0.98 – 1.30) 
1.19 (1.04 – 1.37) 
p-for trend   0.01 0.005 
White (h/d; n = 4,508) - < 6 - 6 – 8.4 - 8.5 – 11.9 - ≥ 12 
 
5,554 
6,532 
5,945 
6,750 
 
140 
176 
156 
213 
 
Reference 
1.10 (0.87 – 1.38) 
1.12 (0.89 – 1.42) 
1.39 (1.11 – 1.74) 
 
Reference 
1.09 (0.87 – 1.36) 
1.12 (0.88 – 1.41) 
1.38 (1.10 – 1.72) 
p-for trend   0.005 0.005 
Males (h/d; n = 5,483)  - < 6  - 6 – 8.4  - 8.5 – 11.9  - ≥ 12  
 
7,491 
7,923 
7,095 
9,354 
 
262 
265 
257 
334 
 
Reference 
0.97 (0.81 – 1.15) 
1.18 (0.99 – 1.41) 
1.20 (1.01 – 1.42) 
 
Reference 
0.98 (0.82 – 1.17) 
1.20 (1.01 – 1.43) 
1.21 (1.02 – 1.44) 
p-for trend   0.007 0.004 
Females (h/d; n = 10,162) - < 6 - 6 – 8.4 - 8.5 – 11.9 - ≥ 12 
 
15,671 
15,340 
14,930 
16,770 
 
300 
324 
285 
343 
 
Reference 
1.09 (0.93 – 1.28) 
1.06 (0.90 – 1.25) 
1.25 (1.07 – 1.48) 
 
Reference 
1.09 (0.93 – 1.28) 
1.06 (0.90 – 1.26) 
1.27 (1.08 – 1.50) 
p-for trend   0.013 0.008 
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Figure 4. Joint effects of total physical activity and total sedentary time on all-cause 
mortality risk among SCCS participants with diabetes 
 
aAdjusted for age, sex, race, BMI, socioeconomic status (education and income), 
smoking, hypertension, high cholesterol, myocardial infarction, stroke, insulin use, 
duration of diabetes. 
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Conclusions 
In this prospective analysis of a racially diverse, low-income population with diabetes, 
we found that higher levels of total physical activity were associated with a nearly 40% 
reduced risk of mortality after adjusting for sedentary time.  Increased total time spent in 
sedentary behaviors was linked to an approximate 25% increase in mortality risk in this 
population after adjusting for physical activity. Further, the analysis of the joint effects of 
both physical activity and sedentary time on mortality risk revealed that across all levels 
of sedentary time, low levels of physical activity were associated with an increased risk 
of death. To our knowledge, the current study contributes the first assessment of the 
independent relationship between total physical activity and sedentary time and 
mortality in both black and white men and women with diabetes, as well as a 
comparison of these associations by race and sex.  Our study also examined this 
association in a population from a low socioeconomic status background, populations 
among whom diabetes prevalence is elevated.  
Our findings are generally consistent with prior studies of mortality among those with 
diabetes, the majority of which were conducted among white men and reported a 
reduced risk of mortality as activity levels increased (4, 5, 7, 9-15, 188-192). The 
strengths of the previously reported associations varied, even among relatively similar 
populations.  Studies of males reported risk reductions ranging from 52-78%(4, 9, 11, 
13, 15, 188) among those with (variously defined) highest vs. lowest physical activity. 
The highest quartile in the current study is lower than some studies that were conducted 
among those with diabetes who were without any other co-morbidities, but higher than 
studies of general populations that tended to adjust for comorbidities.  
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Studies that included both males and females had results ranging from 24-60% 
reductions in risk associated with high physical activity levels (5, 7, 10, 12, 14, 189, 190, 
192).  It is unclear whether the weaker associations observed in mixed-gender 
populations was a result of differences in study methodologies or an actual sex-
difference in the impact of physical activity on mortality among those with diabetes.  The 
overall reduction in mortality risk (37%) we observed was within the range of other 
mixed-gender studies, and our sex-specific results demonstrated, for the first time, 
similar mortality associations in both males and females for both physical activity and 
sedentary time. 
The effect estimates may range between studies in part due to differences in how 
physical activity was measured for each study, as well as how physical activity levels 
were categorized and compared for each study.  Sluik et al. used quartiles for the 
assessment of leisure time physical activity and their top quartile was > 113 MET-
hr/week (corresponds with approximately > 16.1 MET-hr/day).  Mortality risk among 
their top quartile was reduced by almost 40% compared to the lowest quartile (HR 0.62, 
95% CI: [0.46-0.85])(12).  Trichopoulou et al. assessed physical activity using quintiles 
and the highest quintile was ≥ 37 MET-hrs/day.  Those in the highest quintile had a 
decreased mortality risk of more than 20% compared to the lowest quintile (HR 0.76, 
95% CI: [0.63-0.92]) (14).  Quintiles for physical activity were also the exposure variable 
used in the study conducted by Tanasecu et al and the highest quintile (≥ 37.2 MET-
hr/week) also had a decreased risk of mortality compared to those in the lowest quintile 
(HR 0.65, 95% CI: [0.45-0.93])(13).  Our study showed comparable results with the 
reduction in risk being approximately 40%.  Most studies, like ours, assessed self-
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reported total or leisure-time physical activity.  However, studies that measured 
cardiorespiratory fitness as the index of physical activity likewise consistently reported 
inverse associations with mortality in those with diabetes, with risk reductions of 57- 
87% when comparing highest level of activity to lowest (9, 11, 15, 188).  
sedentary time and mortality risk has been explored previously but not specifically 
among those with diabetes.  Most studies have treated sedentary time as if it were the 
inverse of physical activity and have not evaluated its independent association with 
mortality.  Our study demonstrated an increased mortality risk of 18% for those who 
were the most sedentary compared to those who were the least sedentary.  These 
results were after adjustment for physical activity, further highlighting the independence 
of the relationship.  We did however, also explore how physical activity and sedentary 
time interact and effect mortality risk. Across all levels of sedentary time, those in the 
lowest category of physical activity with diabetes (< 6.9 MET-hr/day) were at an 
increased risk of mortality compared to the most active and least sedentary individuals 
with diabetes.  Those who were the least active and most sedentary had the highest risk 
(HR 1.85, 95% CI: [1.53-2.22]).   
Previous investigations also differed regarding covariates used in multivariate models.  
A number of studies did not adjust for diabetes duration or insulin use or diabetes 
medication, which have been previously implicated as significant risk factors for 
mortality among individuals with diabetes(54, 60, 129, 193-195).  Our analysis included 
adjustment for demographic and socioeconomic variables, as well as diabetes duration 
and treatment variables, which were often not included in multivariate models of other 
studies.     
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Currently, the available evidence supporting physical activity as a protective factor 
against mortality for people with diabetes is derived almost exclusively from white 
populations. The only study that published race-specific estimates reported a weaker 
and less graded association among black male veterans than white male veterans (9), 
similar to our findings of qualitatively weaker trends among blacks than whites.  
However, our overall findings do not support a differential effect of physical activity or 
sedentary time on mortality by race, and there would be limited biologic plausibility for 
such an interaction.  
The current study population was racially diverse and by design, black and white SCCS 
participants were of generally similar socioeconomic status, enabling evaluation of the 
risk of mortality with minimal confounding by differences in socioeconomic status (with 
residual confounding adjusted statistically).  The findings of the current study suggest 
that increased physical activity and decreased sedentary time are associated with 
decreased mortality risk in a mainly low-income population with systematic and 
standardized follow-up to determine death status.   
In summary, the findings suggest that increased physical activity and decreased 
sedentary time may be viable prevention efforts to reduce mortality burden within a 
racially diverse, low-income population with diabetes.  The study extends to blacks and 
to women findings that have previously been reported primarily among white men with 
diabetes, and signals that intervention efforts could be similarly effective across gender 
and racial groups. Further research exploring objective, repeated measures of physical 
activity and sedentary time, and examining different types and frequencies of activity 
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suitable for populations with diabetes may help to clarify intervention strategies aimed at 
reducing the burden of this increasingly common illness.    
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CHAPTER 7 
Summary Conclusions and Suggestions for Future Research 
This research is the first to our knowledge to examine physical activity and sedentary 
time in association with CVD risk and all-cause mortality in a racially-diverse population 
of mixed gender with diabetes.  Further, this study population is of low socioeconomic 
status with a high prevalence of CVD risk factors (hypertension, obesity, high 
cholesterol) compared to previous research.  Studies that preceded the current 
research often reported strong, inverse relationships between physical activity and CVD 
(Appendix 3).  Those studies were often conducted among predominantly white males 
with diabetes and of middle to high socioeconomic status.  
Race was not associated with CVD risk among this population of racially-diverse, low-
income adults with diabetes, with nearly equal CVD event rates among both blacks and 
whites.  The high rates of CVD observed among this population may be related to the 
high prevalence of CVD-related risk factors (obesity and hypertension, for example) or 
low socioeconomic status.  Although our study did not find conclusive evidence to 
suggest that physical activity was significantly inversely associated with CVD risk 
among diabetics, increased activity did have a strong, inverse relationship with all-cause 
mortality in this population. Further, low levels of physical activity were significantly 
associated with mortality in every quartile of sedentary time but especially among those 
who were the most sedentary.  Physical activity may need to be accompanied by other 
substantial treatment or management changes to impact CVD risk.  However, as 
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observed in other studies, physical activity is a viable intervention for reducing the gap 
in mortality risk between those with and without diabetes.   
Increased levels of physical activity could serve as an intervention to reduce mortality 
rates among those with diabetes and improve overall, general health.  In the SCCS, 
those with diabetes had almost twice the risk of death compared to those without 
diabetes (13.9% vs. 8.7% respectively; HR: 1.87, 95% CI: 1.76-2.00).  According to the 
results of our analyses, higher levels of physical activity among those with diabetes may 
reduce that gap.  Sedentary time had a significant, positive relationship with mortality, 
even after adjustment for physical activity.  This suggests that, despite the level of 
activity, excessive time spent in sedentary behaviors can be equally as dangerous for 
mortality risk.  Patients should be encouraged to minimize sitting time during the waking 
hours and to meet or exceed the recommended physical activity levels.   
The actual average level of physical activity is difficult to ascertain from self-reported 
information.  However, it is inexpensive and does not have the time intensive 
component of other methods of ascertainment.  The nature of the self-reported physical 
activity exposure may introduce some bias into our study.  We hope that future studies 
will examine these associations using objective measures of activity such as 
accelerometer data. The SCCS PAQ was validated using accelerometer data and 
metrics from this tool are often used to determine activity among study subjects.  
However, it is usually not feasible to get these data on a sample as large as the SCCS. 
While labor intensive and costly, accelerometer data could provide us with a more 
accurate picture of physical activity levels as well as possible differences by race and 
sex.  
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There is no specific recommendation for those with diabetes and diabetes-related 
conditions as to how much activity is necessary to provide a benefit for either CVD or 
mortality.  The currently available literature and recommendations are primarily for those 
without diabetes, or a general population without regard to diabetes.  Diabetes-related 
conditions, such as retinopathy, may prevent those with diabetes from participating in 
moderate-to-vigorous activity so investigating which activities would provide the greatest 
benefit to these individuals could prevent advancement of the disease and reduce the 
incidence of additional comorbidities.   
The replication of the analyses exploring the association between physical activity, 
sedentary time, and CVD as well as mortality would be interesting in a racially-diverse 
set of adults of higher socioeconomic status. Our follow-up data (event ascertainment) 
was from separate data sources.  Had our sample been adequately powered, we could 
have conducted several race- and sex-specific analyses in the younger adults with 
diabetes.  The next steps in research would be to investigate the race-specific risk of 
CVD in association with physical activity and sedentary time among a larger group of 
middle-aged persons with diabetes with a large, alternate source of follow-up data.  
Novel interventions based on the results of those studies to increase activity levels 
among those with diabetes should consider whether race or sex influences the impact 
of physical activity on CVD or mortality.   
It is unclear what role strength training and anaerobic activity plays in the physical 
activity-CVD or physical activity-mortality relationships.  Since the vast majority of 
studies have explored aerobic activity as the exposure representing physical activity, it 
could now be important to add other types of activities into the metric in order to 
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properly assess all activity.  For this to happen, new methods of measuring physical 
activity on a broader, more complete level may need to be developed and validated in a 
variety of populations.  These new methods could be applied widely across health 
conditions and subpopulations. 
Diabetes is a significant global health problem with growing incidence in part due to the 
expansion of elderly and minority populations that are at an increased risk of developing 
diabetes(27, 42, 196-200). Reviving strategies and recommendations for increasing 
physical activity may delay mortality and improve the overall health profile of people with 
diabetes.  However, those strategies and recommendations should be specific and 
evidence-based in their origin. Tailoring physical activity-related interventions to the 
patient and ensuring that the healthcare infrastructure supports those interventions may 
potentially reduce CVD risk and mortality among patients with diabetes.  
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APPENDIX A 
Directed Acyclic Graphs (DAGs) 
(1.1) Race-CVD Association 
 
 
Selected for inclusion in the adjusted models 
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(1.2) Physical Activity and CVD Association 
 
Selected for inclusion in the adjusted models 
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APPENDIX B 
Southern Community Cohort Study Physical Activity Questionnaire (PAQ) 
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APPENDIX C  
Previous Literature Related to Physical Activity, CVD, CVD Mortality, and All-Cause Mortality  
among Subjects with Diabetes 
 
Author(s), 
Year 
Outcomes 
Measure(s) 
Physical 
Activity 
Measure 
Cohort Sample 
Size 
Major Findings/Comments** 
Church, 2005 CVD 
mortality 
CR Fitness Aerobics Center 
Longitudinal Study 
(ACLS) 
2,316 Low fitness level was associated with increased risk 
of CVD mortality within normal weight, overweight, 
and obese weight categories. 
Church, 2004 ACM CR Fitness Aerobics Center 
Longitudinal Study 
(ACLS) 
2,196 There was a steep inverse gradient between fitness 
and mortality in this cohort of men with documented 
diabetes, and this association was independent of 
BMI. 
de Fine 
Olivarius, 
2010 
ACM; CVD 
mortality 
Self-reported 
Leisure Time 
Physical 
Activity 
Diabetes Care in General 
Practice Study 
1,323 Sedentary people were 60% more likely to die than 
active persons with diabetes.  Approximately the 
same HRs for CVD mortality. 
Ford, 1991 ACM; CVD 
mortality 
Self-reported 
leisure-time 
physical 
inactivity 
NHANES I 602 Non-leisure-time physical inactivity was associated 
with all-cause mortality. The strength of the 
associations between risk factors and all-cause and 
coronary heart disease mortality did not differ 
significantly among persons with and 
without diabetes. 
105 
 
   
Gaziano, 
2005 
ACM Self-reported 
Frequency of 
Vigorous 
Exercise 
Physicians’ Health Study 2,838 Exercise is associated with a significant reduction in 
overall mortality among male diabetic physicians 
without a history of MI, stroke, or cancer. The 
association is linear with increasing relative risk 
reduction through to the highest exercise category. 
Hu, 2004 ACM; CVD 
mortality 
Self-reported 
total physical 
activity 
Finnish Population 3,316 Moderate or high levels of physical activity reduce 
total and CVD mortality among patients with type 2 
diabetes. Not only leisure-time physical activity but 
also occupational and commuting physical activities 
are important components of a healthy lifestyle among 
patients with diabetes. 
Hu, 2001 CVD events; 
CVD 
mortality 
Self-reported 
total physical 
activity 
(including 
walking) 
Nurses’ Health Study 5,125 Among diabetic women, increased physical activity, 
including regular walking, is associated with 
substantially reduced risk for cardiovascular events. 
Iijima, 2012 CVD events Self-reported 
physical 
activity 
Japanese Elderly 
Diabetic Intervention Trial 
(J-EDIT) 
938 Lower physical activity is a strong and independent 
predictor of all CVD events in the elderly with type 2 
diabetes beyond traditional risk factors. 
Janevic, 2013 CVD events Self-reported 
physical 
activity 
US Health and 
Retirement Study 
1,811 Adults with diabetes with complications of the eyes, 
kidneys, or nerves and those with heart disease are 
less likely to meet physical activity guidelines 
compared to those without these complications. 
Kokkinos, 
2009 
ACM CR Fitness Veterans Exercise 
Testing Study (VETS) 
3,148 Exercise capacity is a strong predictor of all-cause 
mortality in African American and Caucasian men with 
type 2 diabetes. The exercise capacity-related 
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reduction in mortality appears to be stronger and 
more graded for Caucasians than for African 
Americans. 
Nothlings, 
2010 
ACM Self-reported 
physical 
activity 
European Prospective 
Investigation into Cancer 
and Nutrition (EPIC) – 
Potsdam Study 
1,263 No significant difference in mortality risk in active 
compared to inactive persons  
Nylen, 2013 ACM CR Fitness Veterans Exercise 
Testing Study (VETS) 
2,867 Augmented exercise capacity is associated with lower 
risk of mortality in people with type 2 diabetes aged 
50 to 65 as well as in those older than 65.  
Sluik, 2012 ACM; CVD 
mortality 
Self-reported 
physical 
activity 
European Prospective 
Investigation into Cancer 
and Nutrition (EPIC) 
5,859 Higher levels of physical activity were associated with 
lower mortality risk in individuals with diabetes. Even 
those undertaking moderate amounts of activity were 
at appreciably lower risk for early death compared 
with inactive persons. Compared with physically 
inactive persons, the lowest mortality risk was 
observed in moderately active persons 
Sone, 2013 ACM; CVD 
events 
Self-reported 
physical 
activity 
Japan Diabetes 
Complications Study 
(JDCS) 
1,702 In Japanese persons with type 2 diabetes, LTPA of 
15.4 MET h/week or more was associated with a 
significantly lower risk of stroke partly through 
ameliorating combinations of cardiovascular risk 
factors.  
Spencer, 
2008 
CVD events Self-reported 
physical 
activity 
Million Women Study – 
UK 
25, 915 Incidence of CVD in women with diabetes 4.5 (active) 
and 5 (inactive) per 100 women aged 50-69 over 5 
years.   
Tanasescu, ACM; CVD Self-reported Health Professionals’ 3,058 Physical activity was associated with reduced risk of 
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2003 events physical 
activity 
Follow-up Study (HPFS) CVD, cardiovascular death, and total mortality in men 
with type 2 diabetes. Walking and walking pace were 
associated with reduced total mortality. 
Trichopoulou, 
2006 
ACM Self-reported 
physical 
activity 
European Prospective 
Investigation into Cancer 
and Nutrition (EPIC) – 
Greek study 
1,013 Physical activity was strongly inversely associated 
with mortality. 
Wei, 2000 ACM CR Fitness Aerobics Center 
Longitudinal Study 
(ACLS) 
1,263 Low cardiorespiratory fitness and physical inactivity 
are independent predictors of all-cause mortality in 
men with type 2 diabetes.  
*ACM = all-cause mortality, CR = cardiorespiratory, CVD = cardiovascular disease 
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